{"SLR NAME":"The association between smoking and COVID-19 disease progression","References":[{"title1":"Clinical Characteristics of Covid-19 in New York City","References":[{"title2":"Clinical characteristics of coronavirus disease 2019 in China.","References":[{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia."},{"title3":"Challenges in laboratory diagnosis of the novel coronavirus SARS-CoV-2."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China."},{"title3":"First case of 2019 novel Coronavirus in the United States."},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study."},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome."},{"title3":"A preventive and control strategy for COVID-19 infection: an experience from a Third-Tier Chinese City."},{"title3":"An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies."},{"title3":"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China."},{"title3":"Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2."},{"title3":"COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics."},{"title3":"Transplantation of ACE2(-) mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia."},{"title3":"On the use of corticosteroids for 2019-nCoV pneumonia."},{"title3":"Comprehensive analysis of drugs to treat SARSCoV2 infection: mechanistic insights into current COVID19 therapies (Review)."},{"title3":"The role of telemedicine during the COVID-19 epidemic in China-experience from Shandong province."},{"title3":"Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial."},{"title3":"Intravenous infusion of human umbilical cord Wharton's jelly-derived mesenchymal stem cells as a potential treatment for patients with COVID-19 pneumonia."},{"title3":"Flattening the COVID-19 curve with natural killer cell based immunotherapies."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event."},{"title3":"Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China."},{"title3":"Spatio-temporal metabolokinetics and efficacy of human placenta-derived mesenchymal stem/stromal cells on mice with refractory Crohn's-like enterocutaneous fistula."},{"title3":"High-efficient generation of VCAM-1(+) mesenchymal stem cells with multidimensional superiorities in signatures and efficacy on aplastic anaemia mice."},{"title3":"Systematic comparison of hUC-MSCs at various passages reveals the variations of signatures and therapeutic effect on acute graft-versus-host disease."},{"title3":"JNKi- and DAC-programmed mesenchymal stem/stromal cells from hESCs facilitate hematopoiesis and alleviate hind limb ischemia."},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome."},{"title3":"Studies on viral pneumonia related to novel coronavirus SARS-CoV-2, SARS-CoV, and MERS-CoV: a literature review."},{"title3":"Three emerging coronaviruses in two decades."},{"title3":"The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future."},{"title3":"Coronaviruses - drug discovery and therapeutic options."},{"title3":"The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice."},{"title3":"Acute respiratory distress syndrome: the Berlin Definition."},{"title3":"Pediatric acute respiratory distress syndrome: definition, incidence, and epidemiology: proceedings from the Pediatric Acute Lung Injury Consensus Conference."},{"title3":"Eicosanoid storm in infection and inflammation."},{"title3":"Decoding the enigma of antiviral crisis: does one target molecule regulate all?"}]},{"title2":"Severe outcomes among patients with coronavirus disease 2019 (COVID-19) : United States, February 12-March 16, 2020.","References":[{"title3":"The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China"}]},{"title2":"Obesity and COVID-19 severity in a designated hospital in Shenzhen, China","References":[]}]},{"title1":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title2":"A novel coronavirus associated with severe acute respiratory syndrome","References":[{"title3":"Ahmadi KS, Vahabizad F, Banihashemi G, Sahraian MA,  Gheini MR, Eslami M, Marhamati H, Mirhadi MS (2020) Ischemic stroke in patients with COVID-19 disease: a report of 10 cases from Iran Cerebrovasc Dis 1-6 10.1159/000513279"},{"title3":"Emerging coronaviruses: first SARS, second MERS and third SARS-CoV-2: epidemiological updates of COVID-19"},{"title3":"COVID-19 infection recurrence presenting with meningoencephalitis"},{"title3":"Matos AR, Quintas-Neves M, Oliveira AI, Dias L, Marques S, Carvalho R, Alves JN (2020) COVID-19 associated central nervous system vasculopathy Can J Neurol Sci 1-6 10.1017/cjn.2020.1092020.1092020.1092020.109"},{"title3":"Focal cerebral arteriopathy in a COVID-19 pediatric patient"},{"title3":"An updated review of the association of host genetic factors with susceptibility and resistance to COVID-19"},{"title3":"A first case of meningitis/encephalitis associated with SARS-Coronavirus-2"},{"title3":"COVID-19, SARS and MERS: a neurological perspective"},{"title3":"Frontier therapeutics and vaccine strategies for sars-cov-2 (COVID-19): a review"},{"title3":"A review of Coronavirus Disease-2019 (COVID-19)"},{"title3":"Neurological manifestations in severe acute respiratory syndrome"},{"title3":"Wu Y, Xu X, Chen Z, Duan J, Hashimoto K, Yang L, Liu C, Yang C (2020) Nervous system involvement after infection with COVID-19 and other coronaviruses Brain Behav Immun 18-22 10.1016/j.bbi.2020.03.0312020.03.0312020.03.0312020.03.031"},{"title3":"Encephalitis as a clinical manifestation of COVID-19"},{"title3":"Mild encephalitis/encephalopathy with reversible splenial lesion (MERS) in adults-a case report and literature review"}]},{"title2":"Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome","References":[{"title3":"Severe acute respiratory syndrome (SARS)"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"A cluster of cases of severe acute respiratory syndrome in Hong Kong"},{"title3":"Identification of severe acute respiratory syndrome in Canada"},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Lung pathology of fatal severe acute respiratory syndrome"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Aetiology: Koch's postulates fulfilled for SARS virus"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"Children with respiratory disease associated with metapneumovirus in Hong Kong"},{"title3":"Phylogenetic analysis of a highly conserved region of the polymerase gene from 11 coronaviruses and development of a consensus polymerase chain reaction assay"},{"title3":"Characterization of human metapneumoviruses isolated from patients in North America"},{"title3":"Chan PKS, Tam JS, Lam CW, etal. Detection of human metapneumovirus from patients with severe acute respiratory syndrome: a methodological evaluation. Emerg Infect Dis (in press)."},{"title3":"Detection of influenza A viruses from different species by PCR amplification of conserved sequences in the matrix gene"},{"title3":"Detection of Chlamydia trachomatis in clinical specimens by the polymerase chain reaction"},{"title3":"Rapid and standardised detection of Chlamydia pneumoniae using LightCycler real-time fluorescence PCR"},{"title3":"A newly discovered human metapneumovirus isolated from young children with respiratory tract disease"},{"title3":"Experimental infection of adult axenic rats with Parker's rat coronavirus"},{"title3":"Pathogenicity of experimental infection with 'pneumotropic' porcine coronavirus"},{"title3":"Pathogenicity of porcine respiratory coronavirus isolated in Quebec"},{"title3":"Measles virus and immunomodulation: molecular bases and perspectives"}]},{"title2":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome","References":[]},{"title2":"Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group","References":[]},{"title2":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia","References":[]},{"title2":"Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003","References":[]},{"title2":"Middle East respiratory syndrome coronavirus (MERS-CoV)","References":[]},{"title2":"Novel coronavirus - China","References":[]},{"title2":"Novel coronavirus - Thailand (ex-China)","References":[{"title3":"Life experiences and support perceived by nurses in hospital haemodialysis units during the COVID-19 pandemic in Spain"},{"title3":"Connecting with generation Z: Approaches in nursing education"},{"title3":"Qualitative descriptive methods in health science research"},{"title3":"The characteristic of generation Z"},{"title3":"Nurses at the front line of COVID-19: Roles, responsibilities, risks, and rights"},{"title3":"Implications for COVID-19: A systematic review of nurses' experiences of working in acute care hospital settings during a respiratory pandemic"},{"title3":"Exploring nurses' experiences of psychological distress during care of patients with COVID-19: A qualitative study"},{"title3":"Novice nurse's transitioning to emergency nurse during COVID-19 pandemic: A qualitative study"},{"title3":"Generation Z students: Will they change our nursing classrooms?"},{"title3":"Novice nurses' experiences of unpreparedness at the beginning of the work"},{"title3":"Frontline nurses' burnout, anxiety, depression, and fear statuses and their associated factors during the COVID-19 outbreak in Wuhan, China: A large-scale cross-sectional study"},{"title3":"New graduate nurses' experiences in a clinical specialty: A follow up study of newcomer perceptions of transitional support"},{"title3":"Experiences and psychosocial problems of nurses caring for patients diagnosed with COVID-19 in Turkey: A qualitative study"},{"title3":"Final clinical practicum, transition experience and turnover intentions among newly graduated nurses: A cross sectional study"},{"title3":"The impact of human resource development on organizational effectiveness: An empirical study"},{"title3":"The lived experience of nurses caring for patients with COVID-19 in Iran: A phenomenological study"},{"title3":"The experiences of health-care providers during the COVID-19 crisis in China: A qualitative study"},{"title3":"Experiences of nurses during the COVID-19 pandemic: A mixed-methods study"},{"title3":"Rapid deployment of critical care nurse education during the COVID-19 pandemic"},{"title3":"Effective orientation programs for new graduate nurses: A systematic review"},{"title3":"Exploring nursing managers' perceptions of nursing workforce management during the outbreak of COVID-19: A content analysis study"},{"title3":"Coronavirus infectious disease-2019 (COVID-19): A case report, the first patient in Thailand and outside China"},{"title3":"Nursing experiences of COVID-19 outbreak in Iran: A qualitative study"},{"title3":"Experiences of geriatric nurses in nursing home settings across four countries in the face of the COVID-19 pandemic"},{"title3":"Deciding about the use of a personal safety alerting device:The need for a legitimation process: A qualitative study"},{"title3":"Nurses on the frontline against the COVID-19 pandemic: An integrative review"},{"title3":"The impact of human resource development (HRD) practices on organizational effectiveness: A review"},{"title3":"Holistic care for patients with severe coronavirus disease 2019: An expert consensus"},{"title3":"The experience of transition from nursing students to newly graduated registered nurses in Singapore"},{"title3":"Nurses' psychological changes and coping strategies during home isolation for the 2019 novel coronavirus in China: A qualitative study"}]},{"title2":"Novel coronavirus - Japan (ex-China)","References":[{"title3":"Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle"},{"title3":"WHO. WHO coronavirus (COVID-19) (2022) dashboard https://covid19.who.int/"},{"title3":"Early dynamics of transmission and control of COVID-19: A mathematical modelling study"},{"title3":"A review on COVID-19 forecasting models"},{"title3":"Predictive models of COVID-19 in India: A rapid review"},{"title3":"Forecasting the spread of COVID-19 under different reopening strategies"},{"title3":"A modified age-structured SIR model for COVID-19 type viruses"},{"title3":"Inefficiency of SIR models in forecasting COVID-19 epidemic: A case study of Isfahan"},{"title3":"Baek, J. et al. (2020) The limits to learning an sir process granular for COVID-19. Preprint at arXiv:2006.06373v1"},{"title3":"Quantifying the time-lag effects of human mobility on the COVID-19 transmission: A multi-city study in China"},{"title3":"The effect of population mobility on COVID-19 incidence in 314 Latin American cities: A longitudinal ecological study with mobile phone location data"},{"title3":"Changes in social environment due to the state of emergency and go to campaign during the COVID-19 pandemic in Japan: An ecological study"},{"title3":"The impact of declaring the state of emergency on human mobility during COVID-19 pandemic in Japan"},{"title3":"Mobility network models of COVID-19 explain inequities and inform reopening"},{"title3":"Commentary on Ferguson, et al., impact of non-pharmaceutical interventions (NPIs) to reduce COVID-19 mortality and healthcare demand"},{"title3":"Member of WIN and Gallup International Association. (2022) NR YouGov information https://www.nrc.co.jp/nryg/211227.html"},{"title3":"The &lt;Three Cs&gt; of Japan's pandemic response as an ideograph"},{"title3":"Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England"},{"title3":"Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England"},{"title3":"Agent-based modeling for super-spreading events: A case study of MERS-CoV transmission dynamics in the Republic of Korea"},{"title3":"Mobility change and COVID-19 in Japan: Mobile data analysis of locations of infection"},{"title3":"Non-compulsory measures sufficiently reduced human mobility in Tokyo during the COVID-19 epidemic"},{"title3":"Reduction in mobility and COVID-19 transmission"},{"title3":"The effect of travel restrictions on the spread of the 2019 novel coronavirus (COVID-19) outbreak"},{"title3":"Shorter incubation period among unvaccinated delta variant coronavirus disease 2019 patients in Japan"},{"title3":"Shorter incubation period among COVID-19 cases with the BA.1 Omicron variant"},{"title3":"Association between mobility patterns and COVID-19 transmission in the USA: A mathematical modelling study"},{"title3":"The effect of human mobility and control measures on the COVID-19 epidemic in china"},{"title3":"Ogiwara, K. (2021) Coronavirus disease (COVID-19) situation report in Japan https://toyokeizai.net/sp/visual/tko/covid19/en.html"},{"title3":"Tokyo Metropolitan Government. (2020) Number of Ovid-19 positive cases by date of onset https://stopcovid19.metro.tokyo.lg.jp/cards/positive-number-by-developed-date/"},{"title3":"Number of subscribers by carriers. (2021) Webpage in Japanese. Telecommunications Carriers Association. https://www.tca.or.jp/database/"},{"title3":"A contribution to the mathematical theory of epidemics"},{"title3":"The approximately universal shapes of epidemic curves in the Susceptible-Exposed-Infectious-Recovered (SEIR) model"},{"title3":"Inferring change points in the spread of COVID-19 reveals the effectiveness of interventions"},{"title3":"A cluster analysis method for grouping means in the analysis of variance"},{"title3":"Geometric interpretation of gene coexpression network analysis"},{"title3":"Phylogenetic network analysis of SARS-CoV-2 genomes"},{"title3":"Topological dynamics of the 2015 South Korea MERS-CoV spread-on-contact networks"},{"title3":"Toyo Keizai Online The novel coronavirus diseaseDisease (COVID-19) Situation Report in Japan. https://toyokeizai.net/sp/visual/tko/covid19/en.html."}]},{"title2":"Novel coronavirus - Republic of Korea (ex-China)","References":[{"title3":"Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1"},{"title3":"Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents"},{"title3":"Early Epidemiological and Clinical Characteristics of 28 cases of Coronavirus Disease in South Korea"},{"title3":"Coronavirus Disease-19: Summary of 2,370 contact investigations of the first 30 cases in the Republic of Korea"},{"title3":"Extensive viable Middle East respiratory syndrome (MERS) coronavirus contamination in air and surrounding environment in MERS isolation wards"},{"title3":"Environmental Contamination and Viral Shedding in MERS Patients during MERS-CoV Outbreak in South Korea"},{"title3":"Airflow as a possible transmission route of Middle East respiratory syndrome at an initial outbreak hospital in Korea"},{"title3":"Airflow analysis of Pyeongtaek St. Mary's hospital during hospitalization of the first Middle East respiratory syndrome patient in Korea"},{"title3":"Identification of coronavirus isolated from a patient in Korea with COVID-19"},{"title3":"A lesson from temporary closing of a single university-affiliated hospital owing to in-hospital transmission of coronavirus disease 2019"},{"title3":"Air, surface environmental, and personal protective equipment contamination by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from a symptomatic patient"}]},{"title2":"First travel-related case of 2019 novel coronavirus detected in United States","References":[]},{"title2":"A novel coronavirus genome identified in a cluster of pneumonia cases : Wuhan, China 2019-2020","References":[{"title3":"From &quot;A&quot;IV to &quot;Z&quot;IKV: attacks from emerging and Re-emerging  pathogens"},{"title3":"MAFFT multiple sequence alignment software version 7: improvements in performance and usability"},{"title3":"A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood"}]},{"title2":"Relationship between the presence of hypoxemia and the inflammatory response measured by C-reactive protein in bacteremic pneumococcal pneumonia","References":[]},{"title2":"KDIGO clinical practice guideline for acute kidney injury","References":[]},{"title2":"CDC definitions for nosocomial infections, 1988","References":[]},{"title2":"Association between cardiac injury and mortality in hospitalized patients infected with avian influenza A (H7N9) virus","References":[{"title3":"Epidemiology of avian influenza A H7N9 virus in human beings across five epidemics in mainland China, 2013-17: an epidemiological study of laboratory-confirmed case series."},{"title3":"The re-emergence of highly pathogenic avian influenza H7N9 viruses in humans in mainland China, 2019."},{"title3":"Clinical findings in 111 cases of influenza A (H7N9) virus infection."},{"title3":"Clinicopathologic study of thirty-three fatal cases of Asian influenza."},{"title3":"Observations on the A2 England influenza epidemic: A clinicopathological study."},{"title3":"Echocardiographic manifestations of pandemic 2009 (H1N1) influenza a virus infection."},{"title3":"2009 pandemic H1N1-associated myocarditis in a previously healthy adult."},{"title3":"Influenza myocarditis and myositis: Case presentation and review of the literature."},{"title3":"Cardiac manifestations in patients with pandemic (H1N1) 2009 virus infection needing intensive care."},{"title3":"Cardiac complications of influenza infection in 3 adults."},{"title3":"Acute myocardial infarction after laboratory-confirmed influenza infection."},{"title3":"Cardiac complications associated with the influenza viruses A subtype H7N9 or pandemic H1N1 in critically ill patients under intensive care."},{"title3":"Influenza, autoimmunity and atherogenesis."},{"title3":"Cardiovascular manifestations associated with influenza virus infection."},{"title3":"The cardiovascular manifestations of influenza: a systematic review."},{"title3":"Factors associated with prolonged viral shedding in patients with avian influenza A(H7N9) virus infection."},{"title3":"Epidemiology of human infections with avian influenza A(H7N9) virus in China."},{"title3":"Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: A systematic review."},{"title3":"Fourth Universal Definition of Myocardial Infarction (2018)."},{"title3":"The prevalence and findings of subclinical influenza-associated cardiac abnormalities among Japanese patients."},{"title3":"Accuracy of Doppler-echocardiographic mean pulmonary artery pressure for diagnosis of pulmonary hypertension."},{"title3":"Guidelines for the echocardiographic assessment of the right heart in adults: A report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography."},{"title3":"2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT)."},{"title3":"Acute respiratory distress syndrome: the Berlin Definition."},{"title3":"KDIGO clinical practice guidelines for acute kidney injury."},{"title3":"Use of corticosteroids in acute lung injury and acute respiratory distress syndrome: A systematic review and meta-analysis."},{"title3":"Adjuvant corticosteroid treatment in adults with influenza a (H7N9) viral pneumonia."},{"title3":"A case of influenza type a myocarditis that presents with ST elevation MI, cardiogenic shock, acute renal failure, and rhabdomyolysis and with rapid recovery after treatment with oseltamivir and intra-aortic balloon pump support."},{"title3":"Acute cardiac injury events &lt;=30 days after laboratory-confirmed influenza virus infection among U.S. veterans, 2010-2012."},{"title3":"Positive end-expiratory pressure setting in adults with acute lung injury and acute respiratory distress syndrome: A randomized controlled trial."},{"title3":"Transient cardiac injury during H7N9 infection."},{"title3":"Relation of concomitant heart failure to outcomes in patients hospitalized with influenza."},{"title3":"Extreme influenza epidemics and out-of-hospital cardiac arrest."},{"title3":"Experimental influenza A virus myocarditis in mice. Light and electron microscopic, virologic, and hemodynamic study."},{"title3":"The use of intravenous ribavirin to treat influenza virus-associated acute myocarditis."},{"title3":"Overexpression of tumor necrosis factor (TNF)alpha and TNFalpha receptor I in human viral myocarditis: clinicopathologic correlations."},{"title3":"Fulminant myopericarditis in an immunocompetent adult due to pandemic 2009 (H1N1) influenza A virus infection."},{"title3":"The hidden burden of influenza: A review of the extra-pulmonary complications of influenza infection."},{"title3":"Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia."},{"title3":"Cytokine responses in patients with mild or severe influenza A(H1N1)pdm09."},{"title3":"Vaccine-induced plasma IgA specific for the C1 region of the HIV-1 envelope blocks binding and effector function of IgG."},{"title3":"The association between serum biomarkers and disease outcome in influenza A(H1N1)pdm09 virus infection: Results of two international observational cohort studies."},{"title3":"Myocardial dysfunction in severe sepsis and septic shock: More questions than answers?"},{"title3":"Interferon-beta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction."},{"title3":"Acute infection and myocardial infarction."},{"title3":"Myocardial injury and bacterial pneumonia contribute to the pathogenesis of fatal influenza B virus infection."},{"title3":"Pathophysiology of sepsis-related cardiac dysfunction: driven by inflammation, energy mismanagement, or both?"}]},{"title2":"Coronaviruses post-SARS: update on replication and pathogenesis","References":[{"title3":"Severe acute respiratory syndrome"},{"title3":"Cryo-electron tomography of mouse hepatitis virus: insights into the structure of the coronavirion"},{"title3":"Supramolecular architecture of severe acute respiratory syndrome coronavirus revealed by electron cryomicroscopy"},{"title3":"The molecular biology of coronaviruses"},{"title3":"Luxury at a cost? Recombinant mouse hepatitis viruses expressing the accessory hemagglutinin esterase protein display reduced fitness in vitro"},{"title3":"Ceacam1a-/- mice are completely resistant to infection by murine coronavirus mouse hepatitis virus A59"},{"title3":"Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"The S proteins of human coronavirus NL63 and severe acute respiratory syndrome coronavirus bind overlapping regions of ACE2"},{"title3":"Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry"},{"title3":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury"},{"title3":"Angiotensin-converting enzyme 2 protects from severe acute lung failure"},{"title3":"Induction of prothrombinase fgl2 by the nucleocapsid protein of virulent mouse hepatitis virus is dependent on host hepatic nuclear factor-4alpha"},{"title3":"Severe acute respiratory syndrome-associated coronavirus nucleocapsid protein interacts with Smad3 and modulates transforming growth factor-beta signaling"},{"title3":"A severe acute respiratory syndrome coronavirus that lacks the E gene is attenuated in vitro and in vivo"},{"title3":"The small envelope protein E is not essential for murine coronavirus replication"},{"title3":"Absence of E protein arrests transmissible gastroenteritis coronavirus maturation in the secretory pathway"},{"title3":"Viroporin activity of murine hepatitis virus E protein"},{"title3":"SARS coronavirus E protein forms cation-selective ion channels"},{"title3":"Severe acute respiratory syndrome coronavirus group-specific open reading frames encode nonessential functions for replication in cell cultures and mice"},{"title3":"Inactivation of expression of gene 4 of mouse hepatitis virus strain JHM does not affect virulence in the murine CNS"},{"title3":"The group-specific murine coronavirus genes are not essential, but their deletion, by reverse genetics, is attenuating in the natural host"},{"title3":"Bats are natural reservoirs of SARS-like coronaviruses"},{"title3":"The internal open reading frame within the nucleocapsid gene of mouse hepatitis virus encodes a structural protein that is not essential for viral replication"},{"title3":"Severe acute respiratory syndrome coronavirus accessory protein 6 is a virion-associated protein and is released from 6 protein-expressing cells"},{"title3":"Severe acute respiratory syndrome coronavirus 3a protein is a viral structural protein"},{"title3":"The ORF7b protein of severe acute respiratory syndrome coronavirus (SARS-CoV) is expressed in virus-infected cells and incorporated into SARS-CoV particles"},{"title3":"Proteomics analysis unravels the functional repertoire of coronavirus nonstructural protein 3"},{"title3":"A contemporary view of coronavirus transcription"},{"title3":"Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs"},{"title3":"Insights into SARS-CoV transcription and replication from the structure of the nsp7-nsp8 hexadecamer"},{"title3":"Nuclear magnetic resonance structure shows that the severe acute respiratory syndrome coronavirus-unique domain contains a macrodomain fold"},{"title3":"Crystal structure of nonstructural protein 10 from the severe acute respiratory syndrome coronavirus reveals a novel fold with two zinc-binding motifs"},{"title3":"Crystal structure of a monomeric form of severe acute respiratory syndrome coronavirus endonuclease nsp15 suggests a role for hexamerization as an allosteric switch"},{"title3":"Structural genomics of the severe acute respiratory syndrome coronavirus: nuclear magnetic resonance structure of the protein nsP7"},{"title3":"Structural basis of severe acute respiratory syndrome coronavirus ADP-ribose-1''-phosphate dephosphorylation by a conserved domain of nsP3"},{"title3":"Novel beta -barrel fold in the nuclear magnetic resonance structure of the replicase nonstructural protein 1 from the severe acute respiratory syndrome coronavirus"},{"title3":"Nuclear magnetic resonance structure of the N-terminal domain of nonstructural protein 3 from the severe acute respiratory syndrome coronavirus"},{"title3":"Crystal structure and mechanistic determinants of SARS coronavirus nonstructural protein 15 define an endoribonuclease family"},{"title3":"Dodecamer structure of severe acute respiratory syndrome coronavirus nonstructural protein nsp10"},{"title3":"Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage"},{"title3":"A second, non-canonical RNA-dependent RNA polymerase in SARS coronavirus"},{"title3":"Severe acute respiratory syndrome coronavirus papain-like protease: structure of a viral deubiquitinating enzyme"},{"title3":"Processing of open reading frame 1a replicase proteins nsp7 to nsp10 in murine hepatitis virus strain A59 replication"},{"title3":"The severe acute respiratory syndrome-coronavirus replicative protein nsp9 is a single-stranded RNA-binding subunit unique in the RNA virus world"},{"title3":"Murine hepatitis virus replicase protein nsp10 is a critical regulator of viral RNA synthesis"},{"title3":"High fidelity of murine hepatitis virus replication is decreased in nsp14 exoribonuclease mutants"},{"title3":"Chen, Y. et al. Functional screen reveals SARS coronavirus nonstructural protein nsp14 as a novel cap N7 methyltransferase. Proc. Natl Acad. Sci. USA 10 Feb 2009 (doi:10.1073/pnas.0808790106)."},{"title3":"Major genetic marker of nidoviruses encodes a replicative endoribonuclease"},{"title3":"Coronavirus nonstructural protein 16 is a cap-0 binding enzyme possessing (nucleoside-2'O)-methyltransferase activity"},{"title3":"Ultrastructure and origin of membrane vesicles associated with the severe acute respiratory syndrome coronavirus replication complex"},{"title3":"Molecular interactions in the assembly of coronaviruses"},{"title3":"Coronavirus replication complex formation utilizes components of cellular autophagy"},{"title3":"Coronavirus replication does not require the autophagy gene ATG5"},{"title3":"Coronavirus infection modulates the unfolded protein response and mediates sustained translational repression"},{"title3":"SARS-coronavirus replication is supported by a reticulovesicular network of modified endoplasmic reticulum"},{"title3":"Non-structural proteins 2 and 3 interact to modify host cell membranes during the formation of the arterivirus replication complex"},{"title3":"Mutation in murine coronavirus replication protein nsp4 alters assembly of double membrane vesicles"},{"title3":"Membrane topology of murine coronavirus replicase nonstructural protein 3"},{"title3":"Topology and membrane anchoring of the coronavirus replication complex: Not all hydrophobic domains of nsp3 and nsp6 are membrane spanning"},{"title3":"Localization and membrane topology of coronavirus nonstructural protein 4: involvement of the early secretory pathway in replication"},{"title3":"A prospective hospital-based study of the clinical impact of non-severe acute respiratory syndrome (Non-SARS)-related human coronavirus infection"},{"title3":"Multiple organ infection and the pathogenesis of SARS. J"},{"title3":"A previously undescribed coronavirus associated with respiratory disease in humans"},{"title3":"Identification of a new human coronavirus"},{"title3":"Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia"},{"title3":"Mosaic structure of human coronavirus NL63, one thousand years of evolution"},{"title3":"Croup is associated with the novel coronavirus NL63"},{"title3":"Systematic assembly of a full-length infectious clone of human coronavirus NL63"},{"title3":"Acquisition of macrophage tropism during the pathogenesis of feline infectious peritonitis is determined by mutations in the feline coronavirus spike protein"},{"title3":"Natural history of a recurrent feline coronavirus infection and the role of cellular immunity in survival and disease"},{"title3":"Early death after feline infectious peritonitis virus challenge due to recombinant vaccinia virus immunization"},{"title3":"Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China"},{"title3":"Transmission dynamics of the etiological agent of SARS in Hong Kong: impact of public health interventions"},{"title3":"Molecular evolution of the SARS coronavirus during the course of the SARS epidemic in China"},{"title3":"Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human"},{"title3":"Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2"},{"title3":"Pathways of cross-species transmission of synthetically reconstructed zoonotic severe acute respiratory syndrome coronavirus"},{"title3":"Identification of a novel coronavirus in bats"},{"title3":"Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats"},{"title3":"Extremely low exposure of a community to severe acute respiratory syndrome coronavirus: false seropositivity due to use of bacterially derived antigens"},{"title3":"Synthetic recombinant bat SARS-like coronavirus is infectious in cultured cells and in mice"},{"title3":"Difference in receptor usage between severe acute respiratory syndrome (SARS) coronavirus and SARS-like coronavirus of bat origin"},{"title3":"Complete genomic sequence of human coronavirus OC43: molecular clock analysis suggests a relatively recent zoonotic coronavirus transmission event"},{"title3":"Bovine-like coronaviruses isolated from four species of captive wild ruminants are homologous to bovine coronaviruses based on complete genomic sequences"},{"title3":"Analysis of the genome sequence of an alpaca coronavirus"},{"title3":"Gain, preservation, and loss of a group 1a coronavirus accessory glycoprotein"},{"title3":"Comparative analysis of twelve genomes of three novel group 2c and group 2d coronaviruses reveals unique group and subgroup features"},{"title3":"Detection of group 1 coronaviruses in bats in North America"},{"title3":"Detection and prevalence patterns of group I coronaviruses in bats, northern Germany"},{"title3":"Detection of novel SARS-like and other coronaviruses in bats from Kenya"},{"title3":"Comparative analysis of complete genome sequences of three novel avian coronaviruses reveals a novel group 3c coronavirus"},{"title3":"Detection of a novel and highly divergent coronavirus from asian leopard cats and Chinese ferret badgers in Southern China"},{"title3":"Identification of a novel coronavirus from a beluga whale by using a panviral microarray"},{"title3":"Immunopathogenesis of coronavirus infections: implications for SARS"},{"title3":"Coronavirus infection of the central nervous system: host-virus stand-off"},{"title3":"Memory CD4+ T-cell-mediated protection from lethal coronavirus encephalomyelitis"},{"title3":"Virus-specific antibody, in the absence of T cells, mediates demyelination in mice infected with a neurotropic coronavirus"},{"title3":"Viral expression of CCL2 is sufficient to induce demyelination in RAG1-/- mice infected with a neurotropic coronavirus"},{"title3":"Effective clearance of mouse hepatitis virus from the central nervous system requires both CD4+ and CD8+ T cells"},{"title3":"Pathogenic role for virus-specific CD4 T cells in mice with coronavirus-induced acute encephalitis"},{"title3":"Vaccine efficacy in senescent mice challenged with recombinant SARS-CoV bearing epidemic and zoonotic spike variants"},{"title3":"A mouse-adapted SARS-Coronavirus causes disease and mortality in BALB/c mice"},{"title3":"Aged BALB/c mice as a model for increased severity of severe acute respiratory syndrome in elderly humans"},{"title3":"Group 2 coronaviruses prevent immediate early interferon induction by protection of viral RNA from host cell recognition"},{"title3":"Mouse hepatitis virus does not induce beta interferon synthesis and does not inhibit its induction by double-stranded RNA"},{"title3":"Inhibition of beta interferon induction by severe acute respiratory syndrome coronavirus suggests a two-step model for activation of interferon regulatory factor 3"},{"title3":"Activation of AP-1 signal transduction pathway by SARS coronavirus nucleocapsid protein"},{"title3":"SARS coronavirus proteins Orf 3b, Orf 6, and nucleocapsid function as interferon antagonists"},{"title3":"Mouse hepatitis coronavirus A59 nucleocapsid protein is a type I interferon antagonist"},{"title3":"Severe acute respiratory syndrome coronavirus nsp1 suppresses host gene expression, including that of type I interferon, in infected cells"},{"title3":"Severe acute respiratory syndrome coronavirus evades antiviral signaling: role of nsp1 and rational design of an attenuated strain"},{"title3":"Coronavirus non-structural protein 1 is a major pathogenicity factor: implications for the rational design of coronavirus vaccines"},{"title3":"Severe acute respiratory syndrome coronavirus ORF6 antagonizes STAT1 function by sequestering nuclear import factors on the rough endoplasmic reticulum/Golgi membrane"},{"title3":"Severe acute respiratory syndrome coronavirus protein 6 accelerates murine hepatitis virus infections by more than one mechanism"},{"title3":"Severe acute respiratory syndrome-CoV protein 6 is required for optimal replication"},{"title3":"Severe acute respiratory syndrome coronavirus nsp1 protein suppresses host gene expression by promoting host mRNA degradation"},{"title3":"Regulation of IRF-3-dependent innate immunity by the papain-like protease domain of the severe acute respiratory syndrome coronavirus"},{"title3":"Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome"},{"title3":"Differential regulation of innate and adaptive immune responses in viral encephalitis"},{"title3":"Type I interferons are essential in controlling neurotropic coronavirus infection irrespective of functional CD8 T cells"},{"title3":"Control of coronavirus infection through plasmacytoid dendritic cell-derived type I interferon"},{"title3":"Murine coronavirus mouse hepatitis virus is recognized by MDA5 and induces type I interferon in brain macrophages/microglia"},{"title3":"Type I IFN-mediated protection of macrophages and dendritic cells secures control of murine coronavirus infection"},{"title3":"Expression of elevated levels of pro-inflammatory cytokines in SARS-CoV-infected ACE2+ cells in SARS patients: relation to the acute lung injury and pathogenesis of SARS"},{"title3":"T cell responses to whole SARS coronavirus in humans"},{"title3":"Pathology and pathogenesis of severe acute respiratory syndrome"},{"title3":"The immunobiology of SARS"},{"title3":"Is there an ideal animal model for SARS?"},{"title3":"Lethal infection in K18-hACE2 mice infected with SARS-CoV"},{"title3":"SARS coronavirus infection of mice transgenic for the human angiotensin-converting enzyme 2 (hACE2) virus receptor"},{"title3":"Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2"},{"title3":"Factors associated with psychosis among patients with severe acute respiratory syndrome: a case-control study"},{"title3":"Detection of severe acute respiratory syndrome coronavirus in the brain: potential role of the chemokine mig in pathogenesis"},{"title3":"Mouse-passaged severe acute respiratory syndrome-associated coronavirus leads to lethal pulmonary edema and diffuse alveolar damage in adult but not young mice"},{"title3":"Participation of both host and virus factors in induction of severe acute respiratory syndrome (SARS) in F344 rats infected with SARS coronavirus"},{"title3":"Functional genomics highlights differential induction of antiviral pathways in the lungs of SARS-CoV-infected macaques"},{"title3":"Genomic analysis reveals age-dependent innate immune responses to severe acute respiratory syndrome coronavirus"},{"title3":"Establishment of &quot;The Gene Mine&quot;: a resource for rapid identification of complex trait genes"},{"title3":"SARS: systematic review of treatment effects"},{"title3":"RNA replication of mouse hepatitis virus takes place at double-membrane vesicles"},{"title3":"Mouse hepatitis virus replicase proteins associate with two distinct populations of intracellular membranes"}]},{"title2":"A major outbreak of severe acute respiratory syndrome in Hong Kong","References":[]},{"title2":"Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study","References":[{"title3":"Severe respiratory illness associated with a novel coronavirus: Saudi Arabia and Qatar, 2012"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group"},{"title3":"Global alert and response (GAR): Middle East respiratory syndrome coronavirus (MERS-CoV):update"},{"title3":"Global alert and response (GAR): novel coronavirus summary and literature update"},{"title3":"Global alert and response (GAR): novel coronavirus infection:update (Middle East respiratory syndrome coronavirus)"},{"title3":"Update: severe respiratory illness associated with Middle East respiratory syndrome coronavirus (MERS-CoV):worldwide, 2012-2013"},{"title3":"Rapid risk assessment: update:severe respiratory disease associated with a novel coronavirus"},{"title3":"Epidemiological update: additional confirmed cases of Middle East respiratory syndrome coronavirus (novel coronavirus) in France, Saudi Arabia, and Tunisia"},{"title3":"Table: confirmed cases of Middle East coronavirus infection reported in Europe (n=11 of 53 cases reported worldwide)"},{"title3":"Recovery from severe novel coronavirus infection"},{"title3":"Family cluster of Middle East respiratory syndrome coronavirus infections"},{"title3":"Hospital outbreak of Middle East respiratory syndrome coronavirus"},{"title3":"Novel coronavirus infections in Jordan, April 2012: epidemiological findings from a retrospective investigation"},{"title3":"Severe respiratory illness caused by a novel coronavirus, in a patient transferred to the United Kingdom from the Middle East, September 2012"},{"title3":"Evidence of person-to-person transmission within a family cluster of novel coronavirus infections, United Kingdom, February 2013"},{"title3":"First cases of Middle East respiratory syndrome coronavirus (MERS-CoV) infections in France, investigations and implications for the prevention of human-to-human transmission, France, May 2013"},{"title3":"Clinical features and viral diagnosis of two cases of infection with Middle East respiratory syndrome coronavirus: a report of nosocomial transmission"},{"title3":"Contact investigation of a case of human novel coronavirus infection treated in a German hospital, October-November 2012"},{"title3":"Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection"},{"title3":"Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction"},{"title3":"Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections"},{"title3":"Global alert and response (GAR): Middle East respiratory syndrome coronavirus (MERS-CoV):update"},{"title3":"Prevalence of diabetes mellitus in a Saudi community"},{"title3":"The epidemiology of severe acute respiratory syndrome in the 2003 Hong Kong epidemic: an analysis of all 1755 patients"},{"title3":"Severe acute respiratory syndrome and coronavirus"},{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"Clinical and laboratory features in the early stage of severe acute respiratory syndrome"},{"title3":"Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area"},{"title3":"Features discriminating SARS from other severe viral respiratory tract infections"},{"title3":"Clinical and laboratory features of severe acute respiratory syndrome vis-a-vis onset of fever"},{"title3":"Severe acute respiratory syndrome"},{"title3":"Assessing the pandemic potential of MERS-CoV"},{"title3":"Transmission scenarios for Middle East respiratory syndrome coronavirus (MERS-CoV) and how to tell them apart"},{"title3":"Interhuman transmissibility of Middle East respiratory syndrome coronavirus: estimation of pandemic risk"},{"title3":"Long-term psychological and occupational effects of providing hospital healthcare during SARS outbreak"},{"title3":"Rapid diagnostics urgently needed for killer infections"},{"title3":"Laboratory capability for molecular detection and confirmation of novel coronavirus in Europe, November 2012"}]},{"title2":"Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome","References":[{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"A cluster of cases of severe acute respiratory syndrome in Hong Kong"},{"title3":"Identification of severe acute respiratory syndrome in Canada"},{"title3":"Haematological changes in patients with severe acute respiratory syndrome"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"The genome sequence of the SARS-associated coronavirus"},{"title3":"Characterization of a novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Rapid diagnosis of a coronavirus associated with severe acute respiratory syndrome (SARS)"},{"title3":"Quantitative analysis and prognostic implication of SARS coronavirus RNA in the plasma and serum of patients with severe acute respiratory syndrome"},{"title3":"Clinical presentations and outcome of severe acute respiratory syndrome in children"},{"title3":"Molecular pathways in virus-induced cytokine production"},{"title3":"Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease?"},{"title3":"In vivo studies on cytokine involvement during acute viral respiratory disease of swine: troublesome but rewarding"},{"title3":"Host defense response and outcome in ARDS"},{"title3":"The role of chemokines in the immunopathology of pulmonary disease"},{"title3":"Severe acute respiratory syndrome (SARS)"},{"title3":"Clinical applications of cytokine assays"},{"title3":"Cytometric bead array to measure six cytokines in twenty-five microliters of serum"},{"title3":"The cytokines: physiological and pathophysiological aspects"},{"title3":"Differential role of interleukin-6 in lung inflammation induced by lipoteichoic acid and peptidoglycan from Staphylococcus aureus"},{"title3":"Interleukin-10 and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen presenting capacity of monocytes via down-regulation of class II major histocompatibility complex expression"},{"title3":"IL-12: a key cytokine in immune regulation"},{"title3":"Interleukin-12 regulates the proliferation of Th1, but not Th2 or Th0, clones"},{"title3":"Interleukin 12 induces stable priming for interferon gamma (IFN-gamma) production during differentiation of human T helper (Th) cells and transient IFN-gamma production in established Th2 cell clones"},{"title3":"Interleukin 12: a key modulator of immune function"},{"title3":"Interleukin-12. Biologic activity, therapeutic utility, and role in disease"},{"title3":"Chemokines in acute lung injury"},{"title3":"Evolution of bronchoalveolar cell populations in the adult respiratory distress syndrome"},{"title3":"Lung neutrophils in the adult respiratory distress syndrome. Clinical and pathophysiologic significance"},{"title3":"The role of neutrophil elastase in acute lung injury"},{"title3":"Interactions between neutrophils and cytokines in blood and alveolar spaces during ARDS"},{"title3":"GRO alpha and interleukin-8 in Pneumocystis carinii or bacterial pneumonia and adult respiratory distress syndrome"},{"title3":"Inflammatory cytokines in patients with persistence of the acute respiratory distress syndrome"},{"title3":"Phenotypic characterization of alveolar monocyte recruitment in acute respiratory distress syndrome"},{"title3":"Lung pathology of fatal severe acute respiratory syndrome"},{"title3":"Distinct functions of interferon-gamma for chemokine expression in models of acute lung inflammation"},{"title3":"Induction of cytokines in mice with parainfluenza pneumonia"},{"title3":"Invited review. Cytokine regulation of fever: studies using gene knockout mice"},{"title3":"Chemokines in infectious diseases of the lung"},{"title3":"Anti-interleukin 8 autoantibody: interleukin 8 complexes in the acute respiratory distress syndrome. Relationship between the complexes and clinical disease activity"},{"title3":"Transforming growth factor-beta: a mediator of cell regulation in acute respiratory distress syndrome"},{"title3":"The strategy of blocking the chemokine system to combat disease"},{"title3":"Antichemokine immunotherapy for allergic diseases"}]},{"title2":"MERS-CoV infection in humans is associated with a pro-inflammatory Th1 and Th17 cytokine profile","References":[{"title3":"MERS coronavirus: diagnostics, epidemiology and transmission"},{"title3":"MERS-CoV: where are we now?"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV) infection"},{"title3":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV"},{"title3":"Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26"},{"title3":"Identification of residues on human receptor DPP4 critical for MERS-CoV binding and entry"},{"title3":"Emerging respiratory viral infections: MERS-CoV and influenza"},{"title3":"Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis"},{"title3":"Middle East respiratory syndrome coronavirus &quot;MERS-CoV&quot;: current knowledge gaps"},{"title3":"2015 Middle East Respiratory Syndrome Coronavirus (MERS-CoV) nosocomial outbreak in South Korea: insights from modeling"},{"title3":"Severe respiratory illness caused by a novel coronavirus, in a patient transferred to the United Kingdom from the Middle East, September 2012"},{"title3":"The epidemiology of MERS-CoV"},{"title3":"Emerging viral respiratory tract infections-environmental risk factors and transmission"},{"title3":"Dromedary camels and the transmission of Middle East Respiratory Syndrome Coronavirus (MERS-CoV)"},{"title3":"A. Mailles, K. Blanckaert, P. Chaud, S. van der Werf, B. Lina, V. Caro, et al., First cases of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infections in France, investigations and implications for the prevention of human-to-human transmission, France, May 2013. Euro surveillance: bulletin Europeen sur les maladies transmissibles = European Communicable Disease Bulletin 18 (2013)."},{"title3":"J. Premila Devi, W. Noraini, R. Norhayati, C. Chee Kheong, A.S. Badrul, S. Zainah, et al., Laboratory-confirmed case of Middle East respiratory syndrome coronavirus (MERS-CoV) infection in Malaysia: preparedness and response, April 2014. Euro surveillance: bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin 19 (2014)."},{"title3":"Tracing airline travelers for a public health investigation: Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Infection in the United States, 2014"},{"title3":"T. Briese, N. Mishra, K. Jain, I.S. Zalmout, O.J. Jabado, W.B. Karesh, et al., Middle East respiratory syndrome coronavirus quasispecies that include homologues of human isolates revealed through whole-genome analysis and virus cultured from dromedary camels in Saudi Arabia, mBio 5 (2014) e01146-e01214."},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV): animal to human interaction"},{"title3":"MERS-CoV geography and ecology in the Middle East: analyses of reported camel exposures and a preliminary risk map"},{"title3":"Dromedary MERS-CoV replicates in human respiratory tissues"},{"title3":"Prevalence of Middle East respiratory syndrome coronavirus (MERS-CoV) in dromedary camels in Abu Dhabi Emirate, United Arab Emirates"},{"title3":"Unraveling the drivers of MERS-CoV transmission"},{"title3":"Predictors of MERS-CoV infection: a large case control study of patients presenting with ILI at a MERS-CoV referral hospital in Saudi Arabia"},{"title3":"Infection control and MERS-CoV in health-care workers"},{"title3":"Severe neurologic syndrome associated with Middle East respiratory syndrome corona virus (MERS-CoV)"},{"title3":"Renal complications and their prognosis in Korean patients with Middle East Respiratory Syndrome-Coronavirus from the central MERS-CoV designated hospital"},{"title3":"Acute management and long-term survival among subjects with severe Middle East Respiratory Syndrome coronavirus Pneumonia and Ards"},{"title3":"Hospital outbreak of Middle East respiratory syndrome coronavirus"},{"title3":"Predictive factors for pneumonia development and progression to respiratory failure in MERS-CoV infected patients"},{"title3":"Middle East respiratory syndrome coronavirus in Al-Madinah City, Saudi Arabia: demographic, clinical and survival data"},{"title3":"Guidelines for the laboratory diagnosis of Middle East respiratory syndrome coronavirus in Korea"},{"title3":"Cytometric bead array: a multiplexed assay platform with applications in various areas of biology"},{"title3":"Interferon-gamma: biologic functions and HCV terapy (type I/II) (2 of 2 parts)"},{"title3":"Safety, tolerability, and immunogenicity of interferons"},{"title3":"A tale of two cytokines: IL-17 and IL-22 in asthma and infection"},{"title3":"Tumor necrosis factor (TNF)-alpha and TNF receptors in viral pathogenesis"},{"title3":"Viral and cellular interleukin-10 (IL-10)-related cytokines: from structures to functions"},{"title3":"Infection-induced IL-10 and JAK-STAT: a review of the molecular circuitry controlling immune hyperactivity in response to pathogenic microbes"},{"title3":"MicroRNA regulation of viral immunity, latency, and carcinogenesis of selected tumor viruses and HIV"},{"title3":"Distinct immune response in two MERS-CoV-infected patients: can we go from bench to bedside?"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Virus multiplicity of infection affects type I interferon subtype induction profiles and interferon-stimulated genes"},{"title3":"Interferon-stimulated genes response in endothelial cells following Hantaan virus infection"},{"title3":"Type I interferon induced epigenetic regulation of macrophages suppresses innate and adaptive immunity in acute respiratory viral infection"},{"title3":"T cell-, interleukin-12-, and gamma interferon-driven viral clearance in measles virus-infected brain tissue"},{"title3":"Active replication of Middle East respiratory syndrome coronavirus and aberrant induction of inflammatory cytokines and chemokines in human macrophages: implications for pathogenesis"},{"title3":"Cytokine systems approach demonstrates differences in innate and pro-inflammatory host responses between genetically distinct MERS-CoV isolates"},{"title3":"Coronavirus virulence genes with main focus on SARS-CoV envelope gene"},{"title3":"Tumor necrosis factor alpha exerts powerful anti-influenza virus effects in lung epithelial cells"},{"title3":"L. Josset, V.D. Menachery, L.E. Gralinski, S. Agnihothram, P. Sova, V.S. Carter, et al., Cell host response to infection with novel human coronavirus EMC predicts potential antivirals and important differences with SARS coronavirus, mBio 4 (2013) e00165-e00213."},{"title3":"IL-17 cytokines in immunity and inflammation"},{"title3":"IL-10, T cell exhaustion and viral persistence"},{"title3":"Interleukin-17 promotes autoimmunity by triggering a positive-feedback loop via interleukin-6 induction"},{"title3":"The interleukin-10 signal transduction pathway and regulation of gene expression in mononuclear phagocytes"},{"title3":"Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins"},{"title3":"Interaction between STAT-3 and HNF-3 leads to the activation of liver-specific hepatitis B virus enhancer 1 function"},{"title3":"Hepatitis C virus targets the interferon-alpha JAK/STAT pathway by promoting proteasomal degradation in immune cells and hepatocytes"},{"title3":"Influenza virus non-structural protein 1 (NS1) disrupts interferon signaling"},{"title3":"Tyrosine dephosphorylation of STAT3 in SARS coronavirus-infected Vero E6 cells"},{"title3":"IL-15-PI3K-AKT-mTOR: a critical pathway in the life journey of natural killer cells"},{"title3":"TLR-mediated activation of NK cells and their role in bacterial/viral immune responses in mammals"},{"title3":"The IL-12 family of cytokines in infection, inflammation and autoimmune disorders"},{"title3":"Productive replication of Middle East respiratory syndrome coronavirus in monocyte-derived dendritic cells modulates innate immune response"},{"title3":"Stimulation of IRF-7 gene expression by tumor necrosis factor alpha requirement for NFkappaB transcription factor and gene accessibility"}]},{"title2":"Expression of elevated levels of pro-inflammatory cytokines in SARS-CoV-infected ACE2+ cells in SARS patients: relation to the acute lung injury and pathogenesis of SARS","References":[{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"The genome sequence of the SARS-associated coronavirus"},{"title3":"Characterization of a novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"The SARS-CoV S glycoprotein: expression and functional characterization"},{"title3":"Efficient replication of severe acute respiratory syndrome coronavirus in mouse cells is limited by murine angiotensin-converting enzyme 2"},{"title3":"Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine"},{"title3":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury"},{"title3":"  : Severe acute respiratory syndrome (SARS): multi-country outbreak updated 34. http://www.who.int/csr/don/2003_04_02b/en/index.html."},{"title3":"The clinical pathology of severe acute respiratory syndrome (SARS): a report from China"},{"title3":"Fatal aspergillosis in a patient with SARS who was treated with corticosteroids"},{"title3":"Preparation and characterization of monoclonal antibodies against S1 domain at N-terminal residues 249 to 667 of SARS-associated coronavirus S1 protein"},{"title3":"Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways"},{"title3":"Lung pathology of fatal severe acute respiratory syndrome"},{"title3":"Multiple organ infection and the pathogenesis of SARS"},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis"},{"title3":"Severe acute respiratory syndrome coronavirus fails to activate cytokine-mediated innate immune responses in cultured human monocyte-derived dendritic cells"},{"title3":"Cytokine responses in severe acute respiratory syndrome coronavirus-infected macrophages in vitro: possible relevance to pathogenesis"},{"title3":"Chemokine up-regulation in SARS-coronavirus-infected, monocyte-derived human dendritic cells"},{"title3":"Clinical manifestations and inflammatory cytokine responses in patients with severe acute respiratory syndrome"},{"title3":"A probable role for IFN-gamma in the development of a lung immunopathology in SARS"},{"title3":"Characterization of cytokine/chemokine profiles of severe acute respiratory syndrome"},{"title3":"Early enhanced expression of interferon-inducible protein-10 (CXCL-10) and other chemokines predicts adverse outcome in severe acute respiratory syndrome"},{"title3":"Dynamic changes in clinical features and cytokine/chemokine responses in SARS patients treated with interferon alfacon-1 plus corticosteroids"},{"title3":"Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense"},{"title3":"Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease?"},{"title3":"Herpes simplex virus 1 infection induces the expression of proinflammatory cytokines, interferons and TLR7 in human corneal epithelial cells"},{"title3":"TGF-beta 1 and IFN-gamma direct macrophage activation by TNF-alpha to osteoclastic or cytocidal phenotype"},{"title3":"Macrophages in inflammation"},{"title3":"TGF-beta 1 as an enhancer of Fas-mediated apoptosis of lung epithelial cells"},{"title3":"Science review: apoptosis in acute lung injury"},{"title3":"Role of vascular cell adhesion molecules and leukocyte apoptosis in the lymphopenia and thrombocytopenia of patients with severe acute respiratory syndrome (SARS)"},{"title3":"Transfer of tumor necrosis factor-alpha to rat lung induces severe pulmonary inflammation and patchy interstitial fibrogenesis with induction of transforming growth factor-beta1 and myofibroblasts"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"TGF-beta1 and radiation fibrosis: a master switch and a specific therapeutic target?"},{"title3":"C-reactive protein as a marker for inflammatory bowel disease"},{"title3":"The IkappaB kinase is a key factor in triggering influenza A virus-induced inflammatory cytokine production in airway epithelial cells"},{"title3":"p38 mitogen-activated protein kinase-dependent hyperinduction of tumor necrosis factor alpha expression in response to avian influenza virus H5N1"},{"title3":"Herpes simplex virus 1 infection induces the expression of proinflammatory cytokines, interferons and TLR7 in human corneal epithelial cells"},{"title3":"Severe acute respiratory syndrome"},{"title3":"Longitudinal alteration of circulating dendritic cell subsets and its correlation with steroid treatment in patients with severe acute respiratory syndrome"},{"title3":"The relationship between serum interleukins and T-lymphocyte subsets in patients with severe acute respiratory syndrome"},{"title3":"Recruitment and proliferation of T lymphocytes is supported by IFNgamma- and TNFalpha-activated human osteoblasts: involvement of CD54 (ICAM-1) and CD106 (VCAM-1) adhesion molecules and CXCR3 chemokine receptor"},{"title3":"Pathogenesis of HIV infection: what the virus spares is as important as what it destroys"},{"title3":"HIV: prevention of opportunistic infections"},{"title3":"High-dose pulse versus nonpulse corticosteroid regimens in severe acute respiratory syndrome"},{"title3":"The use of corticosteroid as treatment in SARS was associated with adverse outcomes: a retrospective cohort study"},{"title3":"Osteonecrosis of hip and knee in patients with severe acute respiratory syndrome treated with steroids"},{"title3":"Drugs selectively blocking proinflammatory cytokines and cell receptors"},{"title3":"The comparative pathology of severe acute respiratory syndrome and avian influenza A subtype H5N1:a review"}]},{"title2":"Distinct immune response in two MERS-CoV-infected patients: can we go from bench to bedside?","References":[{"title3":"SARS coronavirus and innate immunity"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study"},{"title3":"Viruses and interferon: a fight for supremacy"},{"title3":"MDA5/RIG-I and virus recognition"},{"title3":"Beyond pattern recognition: five immune checkpoints for scaling the microbial threat"},{"title3":"Coronaviruses post-SARS: update on replication and pathogenesis"},{"title3":"The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses"},{"title3":"NK cells controlling virus-specific T cells: Rheostats for acute vs. persistent infections"},{"title3":"A weak signal for strong responses: interferon-alpha/beta revisited"},{"title3":"MERS-coronavirus replication induces severe in vitro cytopathology and is strongly inhibited by cyclosporin A or interferon- treatment"},{"title3":"Clinical features and viral diagnosis of two cases of infection with Middle East Respiratory Syndrome coronavirus: a report of nosocomial transmission"},{"title3":"Innate immune response to viral infection of the lungs"},{"title3":"Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome"},{"title3":"SARS Immunity and Vaccination"},{"title3":"Expression profile of immune response genes in patients with Severe Acute Respiratory Syndrome"},{"title3":"Cell Host Response to Infection with Novel Human Coronavirus EMC Predicts Potential Antivirals and Important Differences with SARS Coronavirus"},{"title3":"Hepatitis B virus induces IL-23 production in antigen presenting cells and causes liver damage via the IL-23/IL-17 axis"},{"title3":"Th17 cell based vaccines in mucosal immunity"},{"title3":"IL-10 family of cytokines"},{"title3":"Ysebrant de Lendonck L, Tonon S, Nguyen M, Vandevenne P, Welsby I, . (2013) Interferon regulatory factor 3 controls interleukin-17 expression in CD8 T lymphocytes. Proc Natl Acad Sci USA. Available: http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;id=23918362&amp;retmode=ref&amp;cmd=prlinks."},{"title3":"IRF3 polymorphisms induce different innate anti-Theiler's virus immune responses in RAW264.7 macrophages"},{"title3":"Momattin H, Mohammed K, Zumla A, Memish ZA, Al-Tawfiq JA (2013) Therapeutic Options for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) - possible lessons from a systematic review of SARS-CoV therapy. Int J Infect Dis: 1-7. doi:10.1016/j.ijid.2013.07.002."}]},{"title2":"Treatment with interferon-alpha2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques","References":[{"title3":"Anonymous. MERS-COV - Eastern Mediterranean (65) Saudi Arabia, RFI, Qatar. ProMED 20130904.1919328 (2013)."},{"title3":"Pneumonia from human coronavirus in a macaque model"},{"title3":"de Wit, E. et al. Novel human betacoronavirus causes a transient lower respiratory tract infection in a rhesus macaque model. Proc. Natl. Acad. Sci. USA (in the press)."},{"title3":"Centers for Disease Control and Prevention (CDC). Update: Severe respiratory illness associated with Middle East Respiratory Syndrome Coronavirus (MERS-CoV)-worldwide, 2012-2013. MMWR Morb. Mortal. Wkly. Rep.62, 480-483 (2013)."},{"title3":"A family cluster of Middle East Respiratory Syndrome Coronavirus infections related to a likely unrecognized asymptomatic or mild case"},{"title3":"Inhibition of novel beta coronavirus replication by a combination of interferon-alpha2b and ribavirin"},{"title3":"Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"SARS: systematic review of treatment effects"},{"title3":"Retrospective comparison of convalescent plasma with continuing high-dose methylprednisolone treatment in SARS patients"},{"title3":"Pentaglobin in steroid-resistant severe acute respiratory syndrome"},{"title3":"Use of convalescent plasma therapy in SARS patients in Hong Kong"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"Severe acute respiratory syndrome: report of treatment and outcome after a major outbreak"},{"title3":"Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area"},{"title3":"Treatment of severe acute respiratory syndrome with lopinavir/ritonavir: a multicentre retrospective matched cohort study"},{"title3":"Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings"},{"title3":"Interferon alfacon-1 plus corticosteroids in severe acute respiratory syndrome: a preliminary study"},{"title3":"Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction"},{"title3":"Ribavirin potentiates interferon action by augmenting interferon-stimulated gene induction in hepatitis C virus cell culture models"},{"title3":"Interferon signaling and treatment outcome in chronic hepatitis C"},{"title3":"Branch mode selection during early lung development"},{"title3":"Expression of SHH signaling pathway components in the developing human lung"},{"title3":"Mesodermal deletion of transforming growth factor-beta receptor II disrupts lung epithelial morphogenesis: cross-talk between TGF-beta and Sonic hedgehog pathways"},{"title3":"Hedgehog signaling in neonatal and adult lung"},{"title3":"FGF9 and SHH regulate mesenchymal Vegfa expression and development of the pulmonary capillary network"},{"title3":"FGF9 and SHH signaling coordinate lung growth and development through regulation of distinct mesenchymal domains"},{"title3":"The hedgehog system machinery controls transforming growth factor-beta-dependent myofibroblastic differentiation in humans: involvement in idiopathic pulmonary fibrosis"},{"title3":"Oxidative damage and TGF-beta differentially induce lung epithelial cell sonic hedgehog and tenascin-C expression: implications for the regulation of lung remodelling in idiopathic interstitial lung disease"},{"title3":"Activation of the sonic hedgehog signaling controls human pulmonary arterial smooth muscle cell proliferation in response to hypoxia"},{"title3":"Protection from lipopolysaccharide-induced pulmonary microvascular endothelial cell injury by activation of hedgehog signaling pathway"},{"title3":"Key developmental regulators change during hyperoxia-induced injury and recovery in adult mouse lung"},{"title3":"Health Protection Agency (HPA) UK Novel Coronavirus Investigation team. Evidence of person-to-person transmission within a family cluster of novel coronavirus infections, United Kingdom, February 2013. Euro Surveill.18, 20427 (2013)."},{"title3":"Thoracic radiography as a refinement methodology for the study of H1N1 influenza in cynomologus macaques (Macaca fascicularis)"},{"title3":"Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus"},{"title3":"Normalization using weighted negative second order exponential error functions (NeONORM) provides robustness against asymmetries in comparative transcriptome profiles and avoids false calls"},{"title3":"Improving the efficiency of multidimensional scaling in the analysis of high-dimensional data using singular value decomposition"}]},{"title2":"SARS: systematic review of treatment effects","References":[{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":" . WHO coronavirus disease (COVID-19) dashboard. World Health Orgamization; 2021."},{"title3":"The artificial-liver blood-purification system can effectively improve hypercytokinemia for COVID-19"},{"title3":"A complementary critical appraisal on systematic reviews regarding the most efficient therapeutic strategies for the current COVID-19 (SARS-CoV-2) pandemic"},{"title3":"Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia"},{"title3":"The Serum profile of hypercytokinemia factors identified in H7N9-infected patients can predict fatal outcomes"},{"title3":"Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome"},{"title3":"The many faces of cytokine release syndrome-related coagulopathy"},{"title3":"Continuous hemodiafiltration with a cytokine-adsorbing hemofilter for sepsis"},{"title3":"Continuous hemodiafiltration with a cytokine-adsorbing hemofilter in patients with septic shock: a preliminary report"},{"title3":"Therapeutic plasma exchange in patients with COVID-19 pneumonia in intensive care unit: a retrospective study"},{"title3":"Early hemoperfusion for cytokine removal may contribute to prevention of intubation in patients infected with COVID-19"},{"title3":"Thrombotic microangiopathies"},{"title3":"Intensive blood and plasma exchange for treatment of coagulopathy in meningococcemia"},{"title3":"Plasma exchange as rescue therapy in multiple organ failure including acute renal failure"},{"title3":"Successful treatment with plasma exchange followed by intravenous immunoglobulin in a critically ill patient with COVID-19"},{"title3":"Covid-19 vaccine passports: access, equity, and ethics"},{"title3":"PRISMA extension for scoping reviews (PRISMA-ScR): checklist and eExplanation"},{"title3":"Effectiveness of extracorporeal blood purification (hemoadsorption) in patients with severe coronavirus disease 2019 (COVID-19)"},{"title3":"Plasma exchange for COVID-19 thrombo-inflammatory disease"},{"title3":"Plasma exchange: an effective rescue therapy in critically ill patients with coronavirus disease 2019 infection"},{"title3":"Plasmapheresis reduces cytokine and immune cell levels in COVID-19 patients with acute respiratory distress syndrome (ARDS)"},{"title3":"Efficacy of therapeutic plasma exchange in severe COVID-19 patients"},{"title3":"Efficacy of therapeutic plasma exchange in the treatment of penn class 3 and 4 cytokine release syndrome complicating COVID-19"},{"title3":"Hemoperfusion as a potential treatment for critically ill COVID-19 patients with cytokine storm"},{"title3":"Plasma exchange in critically ill COVID-19 patients"},{"title3":"Polymyxin B hemoperfusion in coronavirus disease 2019 patients with endotoxic shock: case series from EUPHAS2 registry"},{"title3":"A case of COVID-19, with cytokine storm, treated by consecutive use of therapeutic plasma exchange followed by convalescent plasma transfusion: a case report"},{"title3":"Application of plasma exchange in association with higher dose CVVH in cytokine storm complicating COVID-19"},{"title3":"Continues renal replacement therapy (CRRT) with disposable hemoperfusion cartridge: a promising option for severe COVID-19"},{"title3":"Continuous extracorporeal treatments in a dialysis patient with COVID-19"},{"title3":"Direct hemoperfusion using a polymyxin B-immobilized polystyrene column for COVID-19"},{"title3":"Hemoperfusion as a supportive treatment in a COVID-19 patient with late pulmonary thromboembolism: a case report"},{"title3":"Hemoperfusion with CytoSorb as adjuvant therapy in critically ill patients with SARS-CoV2 pneumonia"},{"title3":"Plasma exchange in the treatment of thrombotic microangiopathy associated with COVID-19 infection: a case report"},{"title3":"Plasmapheresis treatment in COVID-19-related autoimmune meningoencephalitis: case series"},{"title3":"Polymyxin B haemoperfusion treatment for respiratory failure and hyperferritinaemia due to COVID-19"},{"title3":"Potential effect of blood purification therapy in reducing cytokine storm as a late complication of critically ill COVID-19"}]},{"title2":"Corticosteroids as adjunctive therapy in the treatment of influenza","References":[]},{"title2":"Corticosteroid therapy for critically ill patients with Middle East respiratory syndrome","References":[]},{"title2":"Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected","References":[]},{"title2":"Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings","References":[]},{"title2":"Treatment of Middle East respiratory syndrome with a combination of lopinavir-ritonavir and interferon-beta1b (MIRACLE trial): study protocol for a randomized controlled trial","References":[{"title3":"World Health Organization: Middle East respiratory syndrome coronavirus (MERS-CoV). http://www.who.int/emergencies/mers-cov/en/. Accessed 14 Jan 2018."},{"title3":"Middle East Respiratory Syndrome"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"A review of treatment modalities for Middle East Respiratory Syndrome"},{"title3":"Treatment with interferon-alpha2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques"},{"title3":"IFN-alpha2a or IFN-beta1a in combination with ribavirin to treat Middle East respiratory syndrome coronavirus pneumonia: a retrospective study"},{"title3":"Ribavirin and interferon-alpha2b as primary and preventive treatment for Middle East respiratory syndrome coronavirus: a preliminary report of two cases"},{"title3":"Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study"},{"title3":"Interferon-beta and mycophenolic acid are potent inhibitors of Middle East respiratory syndrome coronavirus in cell-based assays"},{"title3":"Inhibition of novel beta coronavirus replication by a combination of interferon-alpha2b and ribavirin"},{"title3":"Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus"},{"title3":"Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study"},{"title3":"Delayed induction of proinflammatory cytokines and suppression of innate antiviral response by the novel Middle East respiratory syndrome coronavirus: implications for pathogenesis and treatment"},{"title3":"Distinct immune response in two MERS-CoV-infected patients: can we go from bench to bedside?"},{"title3":"Human cell tropism and innate immune system interactions of human respiratory coronavirus EMC compared to those of severe acute respiratory syndrome coronavirus"},{"title3":"MERS-coronavirus replication induces severe in vitro cytopathology and is strongly inhibited by cyclosporin A or interferon-alpha treatment"},{"title3":"Injectable interferon beta-1b for the treatment of relapsing forms of multiple sclerosis"},{"title3":"Tolerability and safety profile of 12- to 28-week treatment with interferon beta-1b 250 and 500 microg QOD in patients with relapsing-remitting multiple sclerosis: a multicenter, randomized, double-blind, parallel-group pilot study"},{"title3":"Interferon beta-1b (betaseron/betaferon) is well tolerated at a dose of 500 microg: interferon dose escalation assessment of safety (IDEAS)"},{"title3":"Efficacy and biological safety of lopinavir/ritonavir based anti-retroviral therapy in HIV-1-infected patients: a meta-analysis of randomized controlled trials"},{"title3":"Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings"},{"title3":"Abbott Laboratories. Product Information: Kaletra . https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021226s030lbl.pdf. Accessed 14 Jan 2018."},{"title3":"Treatment with lopinavir/ritonavir or interferon-beta1b improves outcome of MERS-CoV infection in a nonhuman primate model of common marmoset"},{"title3":"Combination therapy with lopinavir/ritonavir, ribavirin and interferon-alpha for Middle East respiratory syndrome"},{"title3":"Virological and serological analysis of a recent Middle East respiratory syndrome coronavirus infection case on a triple combination antiviral regimen"},{"title3":"Comparative and kinetic analysis of viral shedding and immunological responses in MERS patients representing a broad spectrum of disease severity"},{"title3":"SPIRIT 2013 statement: defining standard protocol items for clinical trials"},{"title3":"Chang, M. Adaptive Design Theory and implementation using SAS and R, 2nd ed. Chapman and Hall/CRC. 2014. Pp. 153-180."},{"title3":"Acute renal failure:definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group"},{"title3":"Corman VM, Eckerle I, Bleicker T, Zaki A, Landt O, Eschbach-Bludau M, van Boheemen S, Gopal R, Ballhause M, Bestebroer TM, 39, et al. Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction. Euro Surveill. 2012;17(39)."},{"title3":"Classification of acute pancreatitis:2012: revision of the Atlanta classification and definitions by international consensus"},{"title3":"Evaluating cancer patients for rehabilitation potential"},{"title3":"U.S. National Library of Medicine. LiverTox. https://livertox.nlm.nih.gov//Lopinavir.htm. Accessed 14 Jan 2018."},{"title3":"Presentation and outcome of Middle East respiratory syndrome in Saudi intensive care unit patients"},{"title3":"Uniform requirements for manuscripts submitted to biomedical journals"},{"title3":"PubMed-cited research articles on the Middle East respiratory syndrome"},{"title3":"Non-randomised Ebola trials:lessons for optimal outbreak research"},{"title3":"Conducting research in disease outbreaks"},{"title3":"Modification of the sample-size and the schedule of interim analyses in survival trials based on data inspections"}]},{"title2":"Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses","References":[{"title3":"Infidelity of SARS-CoV Nsp14-exonuclease mutant virus replication is revealed by complete genome sequencing"},{"title3":"SARS and MERS: recent insights into emerging coronaviruses"},{"title3":"MERS-CoV Antibodies in Humans, Africa, 2013-2014"},{"title3":"Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional, serological study"},{"title3":"A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence"},{"title3":"SARS-like WIV1-CoV poised for human emergence"},{"title3":"Coronaviruses - drug discovery and therapeutic options"},{"title3":"Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys"},{"title3":"Synthesis and antiviral activity of a series of 1'-substituted 4-aza-7,9-dideazaadenosine C-nucleosides"},{"title3":"Release of severe acute respiratory syndrome coronavirus nuclear import block enhances host transcription in human lung cells"},{"title3":"Severe acute respiratory syndrome coronavirus infection of human ciliated airway epithelia: role of ciliated cells in viral spread in the conducting airways of the lungs"},{"title3":"Systematic assembly of a full-length infectious clone of human coronavirus NL63"},{"title3":"Butyrylcholinesterase, paraoxonase, and albumin esterase, but not carboxylesterase, are present in human plasma"},{"title3":"Mechanisms of severe acute respiratory syndrome coronavirus-induced acute lung injury"},{"title3":"New Metrics for Evaluating Viral Respiratory Pathogenesis"},{"title3":"A mouse model for Betacoronavirus subgroup 2c using a bat coronavirus strain HKU5 variant"},{"title3":"Synthetic recombinant bat SARS-like coronavirus is infectious in cultured cells and in mice"},{"title3":"A randomized, double-blind placebo controlled trial of balapiravir, a polymerase inhibitor, in adult dengue patients"},{"title3":"Reduced ribavirin antiviral efficacy via nucleoside transporter-mediated drug resistance"},{"title3":"Reverse genetics with a full-length infectious cDNA of the Middle East respiratory syndrome coronavirus"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"Risk factors for severe illness with 2009 pandemic influenza A (H1N1) virus infection in China"},{"title3":"Viral Load Kinetics of MERS Coronavirus Infection"},{"title3":"Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease"},{"title3":"Inhibition of novel beta coronavirus replication by a combination of interferon-alpha2b and ribavirin"},{"title3":"Interferon-beta and mycophenolic acid are potent inhibitors of Middle East respiratory syndrome coronavirus in cell-based assays"},{"title3":"Ribavirin and interferon-beta synergistically inhibit SARS-associated coronavirus replication in animal and human cell lines"},{"title3":"HIV protease inhibitor nelfinavir inhibits replication of SARS-associated coronavirus"},{"title3":"Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus"},{"title3":"A noncovalent class of papain-like protease/deubiquitinase inhibitors blocks SARS virus replication"},{"title3":"Enhancement of the infectivity of SARS-CoV in BALB/c mice by IMP dehydrogenase inhibitors, including ribavirin"},{"title3":"Treatment With Lopinavir/Ritonavir or Interferon-beta1b Improves Outcome of MERS-CoV Infection in a Nonhuman Primate Model of Common Marmoset"},{"title3":"A mouse model for MERS coronavirus-induced acute respiratory distress syndrome"},{"title3":"Late Ebola virus relapse causing meningoencephalitis: a case report"}]},{"title2":"Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV","References":[{"title3":"SARS and MERS: recent insights into emerging coronaviruses"},{"title3":"Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional, serological study"},{"title3":"Dudas, G., Carvalho, L. M., Rambaut, A. &amp; Bedford, T. MERS-CoV spillover at the camel-human interface. eLife7, e31257 (2018)."},{"title3":"Clinical outcomes of current medical approaches for Middle East respiratory syndrome: a systematic review and meta-analysis"},{"title3":"WHO. Middle East respiratory syndrome coronavirus (MERS-CoV). https://www.who.int/emergencies/mers-cov/en/ (2018)."},{"title3":"MERS-CoV outbreak following a single patient exposure in an emergency room in South Korea: an epidemiological outbreak study"},{"title3":"Kaletra. Highlights of Prescribing Information. https://www.rxabbvie.com/pdf/kaletratabpi.pdf (2017)."},{"title3":"Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus"},{"title3":"Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture"},{"title3":"Interferon-beta and mycophenolic acid are potent inhibitors of Middle East respiratory syndrome coronavirus in cell-based assays"},{"title3":"Treatment with lopinavir/ritonavir or interferon-beta1b improves outcome of MERS-CoV infection in a nonhuman primate model of common marmoset"},{"title3":"Combination therapy with lopinavir/ritonavir, ribavirin and interferon-alpha for Middle East respiratory syndrome"},{"title3":"Virological and serological analysis of a recent Middle East respiratory syndrome coronavirus infection case on a triple combination antiviral regimen"},{"title3":"Treatment of Middle East respiratory syndrome with a combination of lopinavir-ritonavir and interferon-beta1b (MIRACLE trial): study protocol for a randomized controlled trial"},{"title3":"Arabi, Y. M. Twitter account for MIRACLE Trial. (2019)."},{"title3":"GS-5734 and its parent nucleoside analog inhibit Filo-, Pneumo-, and Paramyxoviruses"},{"title3":"Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses"},{"title3":"Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys"},{"title3":"Initiation, extension, and termination of RNA synthesis by a paramyxovirus polymerase"},{"title3":"Tchesnokov, E. P., Feng, J. Y., Porter, D. P. &amp; Gotte, M. Mechanism of inhibition of Ebola virus RNA-dependent RNA polymerase by remdesivir. Viruses11, 326 (2019)."},{"title3":"Broad spectrum antiviral remdesivir inhibits human endemic and zoonotic deltacoronaviruses with a highly divergent RNA dependent RNA polymerase"},{"title3":"A mouse model for MERS coronavirus-induced acute respiratory distress syndrome"},{"title3":"Estimation of inhibitory quotient using a comparative equilibrium dialysis assay for prediction of viral response to hepatitis C virus inhibitors"},{"title3":"Adaptive evolution influences the infectious dose of MERS-CoV necessary to achieve severe respiratory disease"},{"title3":"Serial histopathological examination of the lungs of mice infected with influenza A virus PR8 strain"},{"title3":"An official American Thoracic Society workshop report: features and measurements of experimental acute lung injury in animals"},{"title3":"Arabi, Y. M. MERS-CoV infection treated with a combination of lopinavir/ritonavir and interferon beta-1b (MIRACLE). https://clinicaltrials.gov/ct2/show/NCT02845843 (2016)."},{"title3":"New metrics for evaluating viral respiratory pathogenesis"},{"title3":"Memory CD8 T cells mediate severe immunopathology following respiratory syncytial virus infection"},{"title3":"Lossi, L., Castagna, C. &amp; Merighi, A. Caspase-3 mediated cell death in the normal development of the mammalian cerebellum. Int. J. Mol. Sci.19, 3999 (2018)."},{"title3":"Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor"},{"title3":"Molecular diversity of coronaviruses in bats"},{"title3":"Coronaviruses:drug discovery and therapeutic options"},{"title3":"Therapeutic drug monitoring of lopinavir/ritonavir in pregnancy"},{"title3":"Clinical uses of interferons"},{"title3":"Virus interference. I. The interferon"},{"title3":"Treatment with interferon-alpha2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques"},{"title3":"Rapid generation of a mouse model for Middle East respiratory syndrome"},{"title3":"Protective effect of intranasal regimens containing peptidic Middle East respiratory syndrome coronavirus fusion inhibitor against MERS-CoV infection"},{"title3":"Middle East respiratory syndrome coronavirus causes multiple organ damage and lethal disease in mice transgenic for human dipeptidyl peptidase 4"},{"title3":"Infection with MERS-CoV causes lethal pneumonia in the common marmoset"},{"title3":"Intratracheal exposure of common marmosets to MERS-CoV Jordan-n3/2012 or MERS-CoV EMC/2012 isolates does not result in lethal disease"},{"title3":"IFNlambda is a potent anti-influenza therapeutic without the inflammatory side effects of IFNalpha treatment"},{"title3":"Interferon-lambda mediates non-redundant front-line antiviral protection against influenza virus infection without compromising host fitness"},{"title3":"The Superiority of IFN-lambda as a therapeutic candidate to control acute influenza viral lung infection"},{"title3":"Mouse models of acute respiratory distress syndrome: a review of analytical approaches, pathologic features, and common measurements"},{"title3":"National Institute of Allergy and Infectious Diseases (NIAID). Center, N.I.o.H.C. Investigational Therapeutics for the Treatment of People With Ebola Virus Disease NCT03719586. https://clinicaltrials.gov/ct2/show/NCT03719586?term=NCT03719586&amp;draw=2&amp;rank=1 (2019)."},{"title3":"National Institute of Allergy and Infectious Diseases (NIAID). Center, N.I.o.H.C. GS-5734 to Assess the Antiviral Activity, Longer-Term Clearance of Ebola Virus, and Safety in Male Ebola Survivors With Evidence of Ebola Virus Persistence in Semen NCT02818582. https://clinicaltrials.gov/ct2/show/NCT02818582?term=NCT02818582&amp;draw=2&amp;rank=1 (2019)."},{"title3":"Clinical presentation and outcomes of Middle East respiratory syndrome in the Republic of Korea"},{"title3":"Viral load kinetics of MERS coronavirus infection"},{"title3":"Prophylactic and therapeutic efficacy of mAb treatment against MERS-CoV in common marmosets"},{"title3":"Agostini, M. L. et al. Coronavirus susceptibility to the antiviral remdesivir (GS-5734) is mediated by the viral polymerase and the proofreading exoribonuclease. MBio9, e00221-18(2018)."},{"title3":"Reverse genetics with a full-length infectious cDNA of the Middle East respiratory syndrome coronavirus"},{"title3":"Betaseron. Highlights of Prescribing Information. https://labeling.bayerhealthcare.com/html/products/pi/Betaseron_PI.pdf (2015)."},{"title3":"A simple practice guide for dose conversion between animals and human"},{"title3":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method"}]},{"title2":"Origin and evolution of pathogenic coronaviruses","References":[{"title3":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding"},{"title3":"Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Severe Acute Respiratory Syndrome (SARS) coronavirus ORF8 protein is acquired from SARS-related coronavirus from greater horseshoe bats through recombination"},{"title3":"SARS-CoV-2 and COVID-19: the most important research questions"},{"title3":"New insights into the mechanisms of RNA recombination"},{"title3":"Generation of coronavirus spike deletion variants by high-frequency recombination at regions of predicted RNA secondary structure"},{"title3":"RNA recombination in animal and plant viruses"},{"title3":"Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses"},{"title3":"Adaptive evolution of MERS-CoV to species variation in DPP4"},{"title3":"Bats and coronaviruses"}]},{"title2":"Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor","References":[{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Coronaviruses in bats from Mexico"},{"title3":"Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC"},{"title3":"Bats are natural reservoirs of SARS-like coronaviruses"},{"title3":"Genomic characterization of severe acute respiratory syndrome-related coronavirus in European bats and classification of coronaviruses based on partial RNA-dependent RNA polymerase gene sequences"},{"title3":"Detection of novel SARS-like and other coronaviruses in bats from Kenya"},{"title3":"Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats"},{"title3":"Difference in receptor usage between severe acute respiratory syndrome (SARS) coronavirus and SARS-like coronavirus of bat origin"},{"title3":"Evidence of the recombinant origin of a bat severe acute respiratory syndrome (SARS)-like coronavirus and its implications on the direct ancestor of SARS coronavirus"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2"},{"title3":"Synthetic recombinant bat SARS-like coronavirus is infectious in cultured cells and in mice"},{"title3":"Host range, prevalence, and genetic diversity of adenoviruses in bats"},{"title3":"Generic detection of coronaviruses and differentiation at the prototype strain level by reverse transcription-PCR and nonfluorescent low-density microarray"},{"title3":"Evolutionary relationships between bat coronaviruses and their hosts"},{"title3":"Intraspecies diversity of SARS-like coronaviruses in Rhinolophus sinicus and its implications for the origin of SARS coronaviruses in humans"},{"title3":"Full-length genome sequences of two SARS-like coronaviruses in horseshoe bats and genetic variation analysis"},{"title3":"RDP3: a flexible and fast computer program for analyzing recombination"},{"title3":"Mechanisms of host receptor adaptation by severe acute respiratory syndrome coronavirus"},{"title3":"Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2"},{"title3":"Ecoepidemiology and complete genome comparison of different strains of severe acute respiratory syndrome-related Rhinolophus bat coronavirus in China reveal bats as a reservoir for acute, self-limiting infection that allows recombination events"},{"title3":"Coexistence of different genotypes in the same bat and serological characterization of Rousettus bat coronavirus HKU9 belonging to a novel Betacoronavirus subgroup"},{"title3":"Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human"},{"title3":"Middle East respiratory syndrome coronavirus in bats, Saudi Arabia"},{"title3":"Is the discovery of the novel human betacoronavirus 2c EMC/2012 (HCoV-EMC) the beginning of another SARS-like pandemic?"},{"title3":"Close relative of human Middle East respiratory syndrome coronavirus in bat, South Africa"},{"title3":"Prediction and prevention of the next pandemic zoonosis"},{"title3":"Angiotensin-converting enzyme 2 (ACE2) proteins of different bat species confer variable susceptibility to SARS-CoV entry"}]},{"title2":"Bats as animal reservoirs for the SARS coronavirus: hypothesis proved after 10 years of virus hunting","References":[{"title3":"Synthetic recombinant bat SARS-like coronavirus is infectious in cultured cells and in mice"},{"title3":"Is the discovery of the novel human betacoronavirus 2c EMC/2012 (HCoV-EMC) the beginning of another SARS-like pandemic?"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"First isolation and characterization of bat SARS-like coronaviruses that use the ACE2 receptor"},{"title3":"Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China"},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats"},{"title3":"Receptor recognition and cross-species infections of SARS coronavirus"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"Bats are natural reservoirs of SARS-like coronaviruses"},{"title3":"Full-length genome sequences of two SARS-like coronaviruses in horseshoe bats and genetic variation analysis"},{"title3":"Difference in receptor usage between severe acute respiratory syndrome (SARS) coronavirus and SARS-like coronavirus of bat origin"},{"title3":"Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human"},{"title3":"Molecular evolution of the SARS coronavirus during the course of the SARS epidemic in China"},{"title3":"Detection of novel SARS-like and other coronaviruses in bats from Kenya"},{"title3":"SARS-CoV infection in a restaurant from palm civet"}]}]},{"title1":"Clinical features and treatment of COVID?19 patients in northeast Chongqing","References":[{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: adescriptivestudy"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Lung CT image of a confirmed case of the 2019 novel coronavirus (2019-nCoV) infected pneumonia (With differential diagnosis of the SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Role of neutrophil to lymphocyte and monocyte to lymphocyte ratios in the diagnosis of bacterial infection in patients with fever"},{"title3":"Coronavirus infections-more than just the common cold"},{"title3":"The association between the neutrophil-to-lymphocyte ratio and mortality in critical illness: an observational cohort study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Monocyte/lymphocyte ratio as a better predictor of cardiovascular and all-cause mortality in hemodialysis patients: a prospective cohort study"},{"title3":"Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill"},{"title3":"Neutrophil-lymphocyte ratio as an early new marker in AIV-H7N9-infected patients: a retrospective study"}]},{"title2":"  . Clinical management of severe acute respiratory infection when novel coronavirus (2019-nCoV) infection is suspected: interim guidance, 28 January 2020. World Health Organization. 2020.","References":[]},{"title2":"Diagnosis and treatment of novel coronavirus pneumonia (trial version 5)","References":[]},{"title2":"Effects of matrine combied with baicalin on mouse pneumonia induced by LPS","References":[]},{"title2":"Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment","References":[]},{"title2":"Clinical characteristics of 2019 novel coronavirus infection in China","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"The continuing 2019nCoV epidemic threat of novel coronaviruses to global health  the latest 2019 novel coronavirus outbreak in Wuhan, China"},{"title3":"Outbreak of pneumonia of unknown etiology in Wuhan China: the mystery and the miracle"},{"title3":"Pattern of early human-to-human transmission of Wuhan 2019 novel coronavirus (SARS-CoV-2), December 2019 to January 2020"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster [published online ahead of print, 2020 Jan 24]"},{"title3":"The latest situation of new coronavirus pneumonia as of 24:00 on February"},{"title3":"Statement on the second meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (SARS-CoV-2)"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Pathogenicity and transmissibility of SARS-CoV-2-A quick overview and comparison with other emerging viruses"},{"title3":"The epidemiology of severe acute respiratory syndrome in the 2003 Hong Kong epidemic: an analysis of all 1755 patients"},{"title3":"Notice on issuing a new coronavirus infected pneumonia diagnosis and treatment plan (Trial Version 5)"},{"title3":"Histopathologic changes and SARS-CoV-2 immunostaining in the lung of a patient with COVID-19"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan"},{"title3":"early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"30 January 2020 pneumonia epidemic situation of C SARS-CoV-2 infection in Hubei province, China-Hubei Provincial Health Committee"},{"title3":"4 February 2020 pneumonia epidemic situation of SARS-CoV-2 infection in Hubei province, China-Hubei Provincial Health Committee"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronaviruspneumonia in Wuhan, China: a descriptive study"},{"title3":"Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area"},{"title3":"MERS, SARS and other coronaviruses as causes of pneumonia"},{"title3":"Middle East respiratory syndrome"},{"title3":"Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China"},{"title3":"Eosinophils contribute to innate antiviral immunity and promote clearance of respiratory syncytial virus"},{"title3":"CT imaging features of 2019 novel coronavirus (SARS-CoV-2)"},{"title3":"Radiology of severe acute respiratory syndrome (SARS): the emerging pathologic-radiologic correlates of an emerging disease"},{"title3":"Thin-section CT 12 months after the diagnosis of severe acute respiratory syndrome in pediatric patients"},{"title3":"Optimizing diagnostic strategy for novel coronavirus pneumonia, a multi-center study in Eastern China"},{"title3":"Detection of Covid-19 in children in early January 2020 in Wuhan, China"},{"title3":"National Health Commission. Notice on issuing a nw coronary virus pneumonia diagnosis and treatment plan (Trial Version 7)"}]},{"title2":"Importation and human-to-human transmission of a novel coronavirus in Vietnam","References":[{"title3":"A novel coronavirus from patients with pneumonia in China, 2019."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China."}]},{"title2":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","References":[]},{"title2":"A familial cluster of infection associated with the 2019 novel coronavirus indicating potential person-to-person transmission during the incubation period","References":[]},{"title2":"Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study","References":[{"title3":"Severe respiratory illness associated with a novel coronavirus: Saudi Arabia and Qatar, 2012"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group"},{"title3":"Global alert and response (GAR): Middle East respiratory syndrome coronavirus (MERS-CoV):update"},{"title3":"Global alert and response (GAR): novel coronavirus summary and literature update"},{"title3":"Global alert and response (GAR): novel coronavirus infection:update (Middle East respiratory syndrome coronavirus)"},{"title3":"Update: severe respiratory illness associated with Middle East respiratory syndrome coronavirus (MERS-CoV):worldwide, 2012-2013"},{"title3":"Rapid risk assessment: update:severe respiratory disease associated with a novel coronavirus"},{"title3":"Epidemiological update: additional confirmed cases of Middle East respiratory syndrome coronavirus (novel coronavirus) in France, Saudi Arabia, and Tunisia"},{"title3":"Table: confirmed cases of Middle East coronavirus infection reported in Europe (n=11 of 53 cases reported worldwide)"},{"title3":"Recovery from severe novel coronavirus infection"},{"title3":"Family cluster of Middle East respiratory syndrome coronavirus infections"},{"title3":"Hospital outbreak of Middle East respiratory syndrome coronavirus"},{"title3":"Novel coronavirus infections in Jordan, April 2012: epidemiological findings from a retrospective investigation"},{"title3":"Severe respiratory illness caused by a novel coronavirus, in a patient transferred to the United Kingdom from the Middle East, September 2012"},{"title3":"Evidence of person-to-person transmission within a family cluster of novel coronavirus infections, United Kingdom, February 2013"},{"title3":"First cases of Middle East respiratory syndrome coronavirus (MERS-CoV) infections in France, investigations and implications for the prevention of human-to-human transmission, France, May 2013"},{"title3":"Clinical features and viral diagnosis of two cases of infection with Middle East respiratory syndrome coronavirus: a report of nosocomial transmission"},{"title3":"Contact investigation of a case of human novel coronavirus infection treated in a German hospital, October-November 2012"},{"title3":"Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection"},{"title3":"Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction"},{"title3":"Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections"},{"title3":"Global alert and response (GAR): Middle East respiratory syndrome coronavirus (MERS-CoV):update"},{"title3":"Prevalence of diabetes mellitus in a Saudi community"},{"title3":"The epidemiology of severe acute respiratory syndrome in the 2003 Hong Kong epidemic: an analysis of all 1755 patients"},{"title3":"Severe acute respiratory syndrome and coronavirus"},{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"Clinical and laboratory features in the early stage of severe acute respiratory syndrome"},{"title3":"Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area"},{"title3":"Features discriminating SARS from other severe viral respiratory tract infections"},{"title3":"Clinical and laboratory features of severe acute respiratory syndrome vis-a-vis onset of fever"},{"title3":"Severe acute respiratory syndrome"},{"title3":"Assessing the pandemic potential of MERS-CoV"},{"title3":"Transmission scenarios for Middle East respiratory syndrome coronavirus (MERS-CoV) and how to tell them apart"},{"title3":"Interhuman transmissibility of Middle East respiratory syndrome coronavirus: estimation of pandemic risk"},{"title3":"Long-term psychological and occupational effects of providing hospital healthcare during SARS outbreak"},{"title3":"Rapid diagnostics urgently needed for killer infections"},{"title3":"Laboratory capability for molecular detection and confirmation of novel coronavirus in Europe, November 2012"}]},{"title2":"Severe acute respiratory syndrome: radiographic and CT findings","References":[]},{"title2":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","References":[{"title3":"Outbreak of pneumonia of unknown etiology in Wuhan China: the mystery and the miracle"},{"title3":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - the latest 2019 novel coronavirus outbreak in Wuhan, China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical management of severe acute respiratory infection when Novel coronavirus (nCoV) infection is suspected: interim guidance"},{"title3":"MERS, SARS and other coronaviruses as causes of pneumonia"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Clinical features predicting mortality risk in patients with viral pneumonia: the MuLBSTA score"},{"title3":"Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus"},{"title3":"Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human"},{"title3":"Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation"},{"title3":"Evidence for camel-to-human transmission of MERS coronavirus"},{"title3":"Surveillance of bat coronaviruses in Kenya identifies relatives of human coronaviruses NL63 and 229E and their recombination history"},{"title3":"Origin and evolution of pathogenic coronaviruses"},{"title3":"Fatal swine acute diarrhoea syndrome caused by an HKU2-related coronavirus of bat origin"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for the risk of human transmission"},{"title3":"Wuhan coronavirus has strong ability to infect humans. Press release"},{"title3":"From SARS to MERS, thrusting coronaviruses into the spotlight"},{"title3":"Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis"},{"title3":"Sex-based differences in susceptibility to severe acute respiratory syndrome coronavirus infection"},{"title3":"Sexual dimorphism in innate immunity"},{"title3":"Pathophysiology and burden of infection in patients with diabetes mellitus and peripheral vascular disease: focus on skin and soft-tissue infections"},{"title3":"Clinical findings in 111 cases of influenza A (H7N9) virus infection"},{"title3":"Clinical features of three avian influenza H7N9 virus-infected patients in Shanghai"},{"title3":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV"}]},{"title2":"Characteristics of lymphocyte subsets and cytokines in peripheral blood of 123 hospitalized patients with 2019 novel coronavirus pneumonia (NCP)","References":[]},{"title2":"The first case of 2019 novel coronavirus pneumonia imported into Korea from Wuhan, China: implication for infection prevention and control measures","References":[{"title3":"Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology"},{"title3":"Hosts and sources of endemic human coronaviruses"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"A novel coronavirus from patients with Pneumonia in China, 2019"},{"title3":"Screening for influenza A(H1N1)pdm09, Auckland International Airport, New Zealand"},{"title3":"Clinical and epidemiologic characteristics of spreaders of middle east respiratory syndrome coronavirus during the 2015 outbreak in Korea"},{"title3":"Clinical progression and cytokine profiles of middle east respiratory syndrome coronavirus infection"},{"title3":"Transmission of 2019-nCoV infection from an asymptomatic contact in Germany"}]},{"title2":"Case of the index patient who caused tertiary transmission of COVID-19 infection in Korea: the application of lopinavir/ritonavir for the treatment of COVID-19 infected pneumonia monitored by quantitative RT-PCR","References":[{"title3":"The first case of 2019 novel coronavirus pneumonia imported into Korea from Wuhan, China: implication for infection prevention and control measures"},{"title3":"Psychological distress and infectious disease mortality in the general population"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Transmission of 2019-nCoV Infection from an asymptomatic contact in Germany"},{"title3":"Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China"}]},{"title2":"Expression of elevated levels of pro-inflammatory cytokines in SARS-CoV-infected ACE2+ cells in SARS patients: relation to the acute lung injury and pathogenesis of SARS","References":[{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"The genome sequence of the SARS-associated coronavirus"},{"title3":"Characterization of a novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"The SARS-CoV S glycoprotein: expression and functional characterization"},{"title3":"Efficient replication of severe acute respiratory syndrome coronavirus in mouse cells is limited by murine angiotensin-converting enzyme 2"},{"title3":"Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine"},{"title3":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury"},{"title3":"  : Severe acute respiratory syndrome (SARS): multi-country outbreak updated 34. http://www.who.int/csr/don/2003_04_02b/en/index.html."},{"title3":"The clinical pathology of severe acute respiratory syndrome (SARS): a report from China"},{"title3":"Fatal aspergillosis in a patient with SARS who was treated with corticosteroids"},{"title3":"Preparation and characterization of monoclonal antibodies against S1 domain at N-terminal residues 249 to 667 of SARS-associated coronavirus S1 protein"},{"title3":"Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways"},{"title3":"Lung pathology of fatal severe acute respiratory syndrome"},{"title3":"Multiple organ infection and the pathogenesis of SARS"},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis"},{"title3":"Severe acute respiratory syndrome coronavirus fails to activate cytokine-mediated innate immune responses in cultured human monocyte-derived dendritic cells"},{"title3":"Cytokine responses in severe acute respiratory syndrome coronavirus-infected macrophages in vitro: possible relevance to pathogenesis"},{"title3":"Chemokine up-regulation in SARS-coronavirus-infected, monocyte-derived human dendritic cells"},{"title3":"Clinical manifestations and inflammatory cytokine responses in patients with severe acute respiratory syndrome"},{"title3":"A probable role for IFN-gamma in the development of a lung immunopathology in SARS"},{"title3":"Characterization of cytokine/chemokine profiles of severe acute respiratory syndrome"},{"title3":"Early enhanced expression of interferon-inducible protein-10 (CXCL-10) and other chemokines predicts adverse outcome in severe acute respiratory syndrome"},{"title3":"Dynamic changes in clinical features and cytokine/chemokine responses in SARS patients treated with interferon alfacon-1 plus corticosteroids"},{"title3":"Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense"},{"title3":"Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease?"},{"title3":"Herpes simplex virus 1 infection induces the expression of proinflammatory cytokines, interferons and TLR7 in human corneal epithelial cells"},{"title3":"TGF-beta 1 and IFN-gamma direct macrophage activation by TNF-alpha to osteoclastic or cytocidal phenotype"},{"title3":"Macrophages in inflammation"},{"title3":"TGF-beta 1 as an enhancer of Fas-mediated apoptosis of lung epithelial cells"},{"title3":"Science review: apoptosis in acute lung injury"},{"title3":"Role of vascular cell adhesion molecules and leukocyte apoptosis in the lymphopenia and thrombocytopenia of patients with severe acute respiratory syndrome (SARS)"},{"title3":"Transfer of tumor necrosis factor-alpha to rat lung induces severe pulmonary inflammation and patchy interstitial fibrogenesis with induction of transforming growth factor-beta1 and myofibroblasts"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"TGF-beta1 and radiation fibrosis: a master switch and a specific therapeutic target?"},{"title3":"C-reactive protein as a marker for inflammatory bowel disease"},{"title3":"The IkappaB kinase is a key factor in triggering influenza A virus-induced inflammatory cytokine production in airway epithelial cells"},{"title3":"p38 mitogen-activated protein kinase-dependent hyperinduction of tumor necrosis factor alpha expression in response to avian influenza virus H5N1"},{"title3":"Herpes simplex virus 1 infection induces the expression of proinflammatory cytokines, interferons and TLR7 in human corneal epithelial cells"},{"title3":"Severe acute respiratory syndrome"},{"title3":"Longitudinal alteration of circulating dendritic cell subsets and its correlation with steroid treatment in patients with severe acute respiratory syndrome"},{"title3":"The relationship between serum interleukins and T-lymphocyte subsets in patients with severe acute respiratory syndrome"},{"title3":"Recruitment and proliferation of T lymphocytes is supported by IFNgamma- and TNFalpha-activated human osteoblasts: involvement of CD54 (ICAM-1) and CD106 (VCAM-1) adhesion molecules and CXCR3 chemokine receptor"},{"title3":"Pathogenesis of HIV infection: what the virus spares is as important as what it destroys"},{"title3":"HIV: prevention of opportunistic infections"},{"title3":"High-dose pulse versus nonpulse corticosteroid regimens in severe acute respiratory syndrome"},{"title3":"The use of corticosteroid as treatment in SARS was associated with adverse outcomes: a retrospective cohort study"},{"title3":"Osteonecrosis of hip and knee in patients with severe acute respiratory syndrome treated with steroids"},{"title3":"Drugs selectively blocking proinflammatory cytokines and cell receptors"},{"title3":"The comparative pathology of severe acute respiratory syndrome and avian influenza A subtype H5N1:a review"}]},{"title2":"Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome","References":[{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"A cluster of cases of severe acute respiratory syndrome in Hong Kong"},{"title3":"Identification of severe acute respiratory syndrome in Canada"},{"title3":"Haematological changes in patients with severe acute respiratory syndrome"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"The genome sequence of the SARS-associated coronavirus"},{"title3":"Characterization of a novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Rapid diagnosis of a coronavirus associated with severe acute respiratory syndrome (SARS)"},{"title3":"Quantitative analysis and prognostic implication of SARS coronavirus RNA in the plasma and serum of patients with severe acute respiratory syndrome"},{"title3":"Clinical presentations and outcome of severe acute respiratory syndrome in children"},{"title3":"Molecular pathways in virus-induced cytokine production"},{"title3":"Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease?"},{"title3":"In vivo studies on cytokine involvement during acute viral respiratory disease of swine: troublesome but rewarding"},{"title3":"Host defense response and outcome in ARDS"},{"title3":"The role of chemokines in the immunopathology of pulmonary disease"},{"title3":"Severe acute respiratory syndrome (SARS)"},{"title3":"Clinical applications of cytokine assays"},{"title3":"Cytometric bead array to measure six cytokines in twenty-five microliters of serum"},{"title3":"The cytokines: physiological and pathophysiological aspects"},{"title3":"Differential role of interleukin-6 in lung inflammation induced by lipoteichoic acid and peptidoglycan from Staphylococcus aureus"},{"title3":"Interleukin-10 and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen presenting capacity of monocytes via down-regulation of class II major histocompatibility complex expression"},{"title3":"IL-12: a key cytokine in immune regulation"},{"title3":"Interleukin-12 regulates the proliferation of Th1, but not Th2 or Th0, clones"},{"title3":"Interleukin 12 induces stable priming for interferon gamma (IFN-gamma) production during differentiation of human T helper (Th) cells and transient IFN-gamma production in established Th2 cell clones"},{"title3":"Interleukin 12: a key modulator of immune function"},{"title3":"Interleukin-12. Biologic activity, therapeutic utility, and role in disease"},{"title3":"Chemokines in acute lung injury"},{"title3":"Evolution of bronchoalveolar cell populations in the adult respiratory distress syndrome"},{"title3":"Lung neutrophils in the adult respiratory distress syndrome. Clinical and pathophysiologic significance"},{"title3":"The role of neutrophil elastase in acute lung injury"},{"title3":"Interactions between neutrophils and cytokines in blood and alveolar spaces during ARDS"},{"title3":"GRO alpha and interleukin-8 in Pneumocystis carinii or bacterial pneumonia and adult respiratory distress syndrome"},{"title3":"Inflammatory cytokines in patients with persistence of the acute respiratory distress syndrome"},{"title3":"Phenotypic characterization of alveolar monocyte recruitment in acute respiratory distress syndrome"},{"title3":"Lung pathology of fatal severe acute respiratory syndrome"},{"title3":"Distinct functions of interferon-gamma for chemokine expression in models of acute lung inflammation"},{"title3":"Induction of cytokines in mice with parainfluenza pneumonia"},{"title3":"Invited review. Cytokine regulation of fever: studies using gene knockout mice"},{"title3":"Chemokines in infectious diseases of the lung"},{"title3":"Anti-interleukin 8 autoantibody: interleukin 8 complexes in the acute respiratory distress syndrome. Relationship between the complexes and clinical disease activity"},{"title3":"Transforming growth factor-beta: a mediator of cell regulation in acute respiratory distress syndrome"},{"title3":"The strategy of blocking the chemokine system to combat disease"},{"title3":"Antichemokine immunotherapy for allergic diseases"}]},{"title2":"Treatment with interferon-alpha2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques","References":[{"title3":"Anonymous. MERS-COV - Eastern Mediterranean (65) Saudi Arabia, RFI, Qatar. ProMED 20130904.1919328 (2013)."},{"title3":"Pneumonia from human coronavirus in a macaque model"},{"title3":"de Wit, E. et al. Novel human betacoronavirus causes a transient lower respiratory tract infection in a rhesus macaque model. Proc. Natl. Acad. Sci. USA (in the press)."},{"title3":"Centers for Disease Control and Prevention (CDC). Update: Severe respiratory illness associated with Middle East Respiratory Syndrome Coronavirus (MERS-CoV)-worldwide, 2012-2013. MMWR Morb. Mortal. Wkly. Rep.62, 480-483 (2013)."},{"title3":"A family cluster of Middle East Respiratory Syndrome Coronavirus infections related to a likely unrecognized asymptomatic or mild case"},{"title3":"Inhibition of novel beta coronavirus replication by a combination of interferon-alpha2b and ribavirin"},{"title3":"Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"SARS: systematic review of treatment effects"},{"title3":"Retrospective comparison of convalescent plasma with continuing high-dose methylprednisolone treatment in SARS patients"},{"title3":"Pentaglobin in steroid-resistant severe acute respiratory syndrome"},{"title3":"Use of convalescent plasma therapy in SARS patients in Hong Kong"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"Severe acute respiratory syndrome: report of treatment and outcome after a major outbreak"},{"title3":"Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area"},{"title3":"Treatment of severe acute respiratory syndrome with lopinavir/ritonavir: a multicentre retrospective matched cohort study"},{"title3":"Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings"},{"title3":"Interferon alfacon-1 plus corticosteroids in severe acute respiratory syndrome: a preliminary study"},{"title3":"Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction"},{"title3":"Ribavirin potentiates interferon action by augmenting interferon-stimulated gene induction in hepatitis C virus cell culture models"},{"title3":"Interferon signaling and treatment outcome in chronic hepatitis C"},{"title3":"Branch mode selection during early lung development"},{"title3":"Expression of SHH signaling pathway components in the developing human lung"},{"title3":"Mesodermal deletion of transforming growth factor-beta receptor II disrupts lung epithelial morphogenesis: cross-talk between TGF-beta and Sonic hedgehog pathways"},{"title3":"Hedgehog signaling in neonatal and adult lung"},{"title3":"FGF9 and SHH regulate mesenchymal Vegfa expression and development of the pulmonary capillary network"},{"title3":"FGF9 and SHH signaling coordinate lung growth and development through regulation of distinct mesenchymal domains"},{"title3":"The hedgehog system machinery controls transforming growth factor-beta-dependent myofibroblastic differentiation in humans: involvement in idiopathic pulmonary fibrosis"},{"title3":"Oxidative damage and TGF-beta differentially induce lung epithelial cell sonic hedgehog and tenascin-C expression: implications for the regulation of lung remodelling in idiopathic interstitial lung disease"},{"title3":"Activation of the sonic hedgehog signaling controls human pulmonary arterial smooth muscle cell proliferation in response to hypoxia"},{"title3":"Protection from lipopolysaccharide-induced pulmonary microvascular endothelial cell injury by activation of hedgehog signaling pathway"},{"title3":"Key developmental regulators change during hyperoxia-induced injury and recovery in adult mouse lung"},{"title3":"Health Protection Agency (HPA) UK Novel Coronavirus Investigation team. Evidence of person-to-person transmission within a family cluster of novel coronavirus infections, United Kingdom, February 2013. Euro Surveill.18, 20427 (2013)."},{"title3":"Thoracic radiography as a refinement methodology for the study of H1N1 influenza in cynomologus macaques (Macaca fascicularis)"},{"title3":"Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus"},{"title3":"Normalization using weighted negative second order exponential error functions (NeONORM) provides robustness against asymmetries in comparative transcriptome profiles and avoids false calls"},{"title3":"Improving the efficiency of multidimensional scaling in the analysis of high-dimensional data using singular value decomposition"}]},{"title2":"Distinct immune response in two MERS-CoV-infected patients: can we go from bench to bedside?","References":[{"title3":"SARS coronavirus and innate immunity"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study"},{"title3":"Viruses and interferon: a fight for supremacy"},{"title3":"MDA5/RIG-I and virus recognition"},{"title3":"Beyond pattern recognition: five immune checkpoints for scaling the microbial threat"},{"title3":"Coronaviruses post-SARS: update on replication and pathogenesis"},{"title3":"The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses"},{"title3":"NK cells controlling virus-specific T cells: Rheostats for acute vs. persistent infections"},{"title3":"A weak signal for strong responses: interferon-alpha/beta revisited"},{"title3":"MERS-coronavirus replication induces severe in vitro cytopathology and is strongly inhibited by cyclosporin A or interferon- treatment"},{"title3":"Clinical features and viral diagnosis of two cases of infection with Middle East Respiratory Syndrome coronavirus: a report of nosocomial transmission"},{"title3":"Innate immune response to viral infection of the lungs"},{"title3":"Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome"},{"title3":"SARS Immunity and Vaccination"},{"title3":"Expression profile of immune response genes in patients with Severe Acute Respiratory Syndrome"},{"title3":"Cell Host Response to Infection with Novel Human Coronavirus EMC Predicts Potential Antivirals and Important Differences with SARS Coronavirus"},{"title3":"Hepatitis B virus induces IL-23 production in antigen presenting cells and causes liver damage via the IL-23/IL-17 axis"},{"title3":"Th17 cell based vaccines in mucosal immunity"},{"title3":"IL-10 family of cytokines"},{"title3":"Ysebrant de Lendonck L, Tonon S, Nguyen M, Vandevenne P, Welsby I, . (2013) Interferon regulatory factor 3 controls interleukin-17 expression in CD8 T lymphocytes. Proc Natl Acad Sci USA. Available: http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;id=23918362&amp;retmode=ref&amp;cmd=prlinks."},{"title3":"IRF3 polymorphisms induce different innate anti-Theiler's virus immune responses in RAW264.7 macrophages"},{"title3":"Momattin H, Mohammed K, Zumla A, Memish ZA, Al-Tawfiq JA (2013) Therapeutic Options for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) - possible lessons from a systematic review of SARS-CoV therapy. Int J Infect Dis: 1-7. doi:10.1016/j.ijid.2013.07.002."}]},{"title2":"On the use of corticosteroids for 2019-nCoV pneumonia","References":[{"title3":"Low-dose corticosteroid therapy does not delay viral clearance in patients with COVID-19"},{"title3":"SARS: systematic review of treatment effects"},{"title3":"Corticosteroids in patients hospitalized with community-acquired pneumonia: systematic review and individual patient data metaanalysis"},{"title3":"Treatment of severe acute respiratory syndrome with glucosteroids: the Guangzhou experience"},{"title3":"[Expert consensus on the use of corticosteroid in patients with 2019-nCoV pneumonia]"},{"title3":"Use of corticosteroids in treating infectious diseases"},{"title3":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China"},{"title3":"Dexamethasone in hospitalized patients with Covid-19 - preliminary report"}]},{"title2":"SARS: systematic review of treatment effects","References":[{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":" . WHO coronavirus disease (COVID-19) dashboard. World Health Orgamization; 2021."},{"title3":"The artificial-liver blood-purification system can effectively improve hypercytokinemia for COVID-19"},{"title3":"A complementary critical appraisal on systematic reviews regarding the most efficient therapeutic strategies for the current COVID-19 (SARS-CoV-2) pandemic"},{"title3":"Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia"},{"title3":"The Serum profile of hypercytokinemia factors identified in H7N9-infected patients can predict fatal outcomes"},{"title3":"Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome"},{"title3":"The many faces of cytokine release syndrome-related coagulopathy"},{"title3":"Continuous hemodiafiltration with a cytokine-adsorbing hemofilter for sepsis"},{"title3":"Continuous hemodiafiltration with a cytokine-adsorbing hemofilter in patients with septic shock: a preliminary report"},{"title3":"Therapeutic plasma exchange in patients with COVID-19 pneumonia in intensive care unit: a retrospective study"},{"title3":"Early hemoperfusion for cytokine removal may contribute to prevention of intubation in patients infected with COVID-19"},{"title3":"Thrombotic microangiopathies"},{"title3":"Intensive blood and plasma exchange for treatment of coagulopathy in meningococcemia"},{"title3":"Plasma exchange as rescue therapy in multiple organ failure including acute renal failure"},{"title3":"Successful treatment with plasma exchange followed by intravenous immunoglobulin in a critically ill patient with COVID-19"},{"title3":"Covid-19 vaccine passports: access, equity, and ethics"},{"title3":"PRISMA extension for scoping reviews (PRISMA-ScR): checklist and eExplanation"},{"title3":"Effectiveness of extracorporeal blood purification (hemoadsorption) in patients with severe coronavirus disease 2019 (COVID-19)"},{"title3":"Plasma exchange for COVID-19 thrombo-inflammatory disease"},{"title3":"Plasma exchange: an effective rescue therapy in critically ill patients with coronavirus disease 2019 infection"},{"title3":"Plasmapheresis reduces cytokine and immune cell levels in COVID-19 patients with acute respiratory distress syndrome (ARDS)"},{"title3":"Efficacy of therapeutic plasma exchange in severe COVID-19 patients"},{"title3":"Efficacy of therapeutic plasma exchange in the treatment of penn class 3 and 4 cytokine release syndrome complicating COVID-19"},{"title3":"Hemoperfusion as a potential treatment for critically ill COVID-19 patients with cytokine storm"},{"title3":"Plasma exchange in critically ill COVID-19 patients"},{"title3":"Polymyxin B hemoperfusion in coronavirus disease 2019 patients with endotoxic shock: case series from EUPHAS2 registry"},{"title3":"A case of COVID-19, with cytokine storm, treated by consecutive use of therapeutic plasma exchange followed by convalescent plasma transfusion: a case report"},{"title3":"Application of plasma exchange in association with higher dose CVVH in cytokine storm complicating COVID-19"},{"title3":"Continues renal replacement therapy (CRRT) with disposable hemoperfusion cartridge: a promising option for severe COVID-19"},{"title3":"Continuous extracorporeal treatments in a dialysis patient with COVID-19"},{"title3":"Direct hemoperfusion using a polymyxin B-immobilized polystyrene column for COVID-19"},{"title3":"Hemoperfusion as a supportive treatment in a COVID-19 patient with late pulmonary thromboembolism: a case report"},{"title3":"Hemoperfusion with CytoSorb as adjuvant therapy in critically ill patients with SARS-CoV2 pneumonia"},{"title3":"Plasma exchange in the treatment of thrombotic microangiopathy associated with COVID-19 infection: a case report"},{"title3":"Plasmapheresis treatment in COVID-19-related autoimmune meningoencephalitis: case series"},{"title3":"Polymyxin B haemoperfusion treatment for respiratory failure and hyperferritinaemia due to COVID-19"},{"title3":"Potential effect of blood purification therapy in reducing cytokine storm as a late complication of critically ill COVID-19"}]},{"title2":"Treatment of severe acute respiratory syndrome with glucosteroids: the Guangzhou experience","References":[{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Treatment of severe acute respiratory syndrome"},{"title3":"Description and clinical treatment of an early outbreak of severe acute respiratory syndrome (SARS) in Guangzhou, PR China"},{"title3":"Development of a standard treatment protocol for severe acute respiratory syndrome"},{"title3":"High dose pulse versus non-pulse corticosteroid regimens in severe acute respiratory syndrome"},{"title3":"Use of glucocorticoid in treatment of severe acute respiratory syndrome cases"},{"title3":"Glucocorticoid-induced diabetes in severe acute respiratory syndrome: the impact of high dosage and duration of methylprednisolone therapy"},{"title3":"Severe acute respiratory syndrome: report of treatment and outcome after a major outbreak"},{"title3":"Management and prevention of SARS in China"},{"title3":"Medical treatment of viral pneumonia including SARS in immunocompetent adult"},{"title3":"SARS: pharmacotherapy"},{"title3":"High dose intravenous methylprednisolone in the treatment of severe acute respiratory syndrome"},{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"The clinical characteristics of secondary infections of lower respiratory tract in severe acute respiratory syndrome"},{"title3":"Nosocomial infections and nosocomial pneumonia"},{"title3":"Chinese Medical Association. Guidelines for management of atypical pneumonia (SARS)"},{"title3":"Comparative study of clinical characteristics and prognosis of clinically diagnosed SARS patients with positive and negative serum SARS coronavirus-specific antibodies test"},{"title3":"A preliminary study of serum antibody level in SARS patients"},{"title3":"Severe acute respiratory syndrome (SARS): a challenge for diagnosis and treatment"},{"title3":"Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February, 2003"},{"title3":"Glucocorticoid in the treatment of severe acute respiratory syndrome patients: a preliminary report"},{"title3":"Effects of early corticosteroid treatment on plasma SARS-associated Coronavirus RNA concentrations in adult patients"},{"title3":"Coronavirus-positive nasopharyngeal aspirate as predictor for severe acute respiratory syndrome mortality"},{"title3":"High dose methylprednisolone in a porcine model of ARDS induced by endotoxemia"},{"title3":"Ineffectiveness of high dose methylprednisolone in preventing parenchymal lung injury and improving mortality in patients with septic shock"},{"title3":"High dose corticosteroids in patients with the adult respiratory distress syndrome"},{"title3":"Prolonged methylprednisolone treatment suppresses systemic inflammation in patients with unresolving acute respiratory distress syndrome"},{"title3":"Respiratory and cadiovascular management of septic ALI-ARDS and shock"},{"title3":"Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS: plasma IL-1 beta and IL-6 levels are consistent and efficient predictors of outcome over time"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"Characterization of cytokine/chemokine profiles of severe acute respiratory syndrome"},{"title3":"Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome"},{"title3":"Prolonged disturbances ofin vitrocytokine production in patients with severe acute respiratory syndrome treated with ribavirin and steroids"},{"title3":"Report on the investigation of lower extremity osteonecrosis with magnetic resonance imaging in recovered severe acute respiratory syndrome in Guangzhou"},{"title3":"Osteonecrosis of hip and knee in patients with severe acute respiratory syndrome treated with steroids"},{"title3":"Factors of avascular necrosis of femoral head and osteoporosis in SARS patients' convalescence"},{"title3":"Avascular necrosis of bone in severe acute respiratory syndrome"}]},{"title2":"Expert consensus on the use of corticosteroid in patients with 2019-nCoV pneumonia","References":[]},{"title2":"Application of Chinese medicine in acute and critical medical conditions","References":[]}]},{"title1":"Epidemiological and clinical features of 125 Hospitalized Patients with COVID-19 in Fuyang, Anhui, China","References":[{"title2":"Critical care management of adults with community-acquired severe respiratory viral infection","References":[{"title3":"Lower respiratory tract virus findings in mechanically ventilated patients with severe community-acquired pneumonia"},{"title3":"The role of human metapneumovirus in the critically ill adult patient"},{"title3":"Emerging novel and antimicrobial-resistant respiratory tract infections: new drug development and therapeutic options"},{"title3":"Hanfelt-Goade D, Maimon N, Nimer A, et al A phase 2b, randomized, double-blind, placebo-controlled trial of presatovir (GS-5806), a novel oral rsv fusion inhibitor, for the treatment of respiratory syncytial virus (RSV) in hospitalized adults American Thoracic Society 2018 international conference, San Diego, 2018: abstract A4457"},{"title3":"Efficacy and safety of nitazoxanide in addition to standard of care for the treatment of severe acute respiratory illness"},{"title3":"Advances in respiratory virus therapeutics:a meeting report from the 6th isirv Antiviral Group conference"},{"title3":"Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data"},{"title3":"Effectiveness of antiviral treatment in human influenza A(H5N1) infections: analysis of a Global Patient Registry"},{"title3":"Treatment with neuraminidase inhibitors for critically ill patients with influenza A (H1N1)pdm09"},{"title3":"Clinical practice guidelines by the infectious diseases society of America: 2018 update on diagnosis, treatment, chemoprophylaxis, and institutional outbreak management of seasonal influenzaa"},{"title3":"High-dose versus standard dose oseltamivir for treatment of severe influenza in adult intensive care unit patients"},{"title3":"A prospective intervention study on higher-dose oseltamivir treatment in adults hospitalized with influenza a and B infections"},{"title3":"Comparison of high-dose versus standard dose oseltamivir in critically ill patients with influenza"},{"title3":"Effect of double dose oseltamivir on clinical and virological outcomes in children and adults admitted to hospital with severe influenza: double blind randomised controlled trial"},{"title3":"Impact of extracorporeal membrane oxygenation and continuous venovenous hemodiafiltration on the pharmacokinetics of oseltamivir carboxylate in critically ill patients with pandemic (H1N1) influenza"},{"title3":"Viral clearance and inflammatory response patterns in adults hospitalized for pandemic 2009 influenza A(H1N1) virus pneumonia"},{"title3":"Oseltamivir resistance in severe influenza A(H1N1)pdm09 pneumonia and acute respiratory distress syndrome: a French multicenter observational cohort study"},{"title3":"Intravenous zanamivir or oral oseltamivir for hospitalised patients with influenza: an international, randomised, double-blind, double-dummy, phase 3 trial"},{"title3":"Evaluation of intravenous peramivir for treatment of influenza in hospitalized patients"},{"title3":"Influenza virus polymerase inhibitors in clinical development"},{"title3":"LB16. Phase 3 trial of baloxavir marboxil in high-risk influenza patients (CAPSTONE-2 study)"},{"title3":"Efficacy of clarithromycin-naproxen-oseltamivir combination in the treatment of patients hospitalized for influenza A(H3N2) infection: an open-label randomized, controlled, phase IIb/III trial"},{"title3":"Macrolide-based regimens in absence of bacterial co-infection in critically ill H1N1 patients with primary viral pneumonia"},{"title3":"Macrolides in critically ill patients with Middle East Respiratory Syndrome"},{"title3":"Early use of glucocorticoids was a risk factor for critical disease and death from pH1N1 infection"},{"title3":"The influence of corticosteroid treatment on the outcome of influenza A(H1N1pdm09)-related critical illness"},{"title3":"The effect of steroid use in hospitalized adults with respiratory syncytial virus-related illness"},{"title3":"Effects of early corticosteroid treatment on plasma SARS-associated Coronavirus RNA concentrations in adult patients"},{"title3":"Corticosteroid therapy for critically ill patients with middle east respiratory syndrome"},{"title3":"Hyperinduction of cyclooxygenase-2-mediated proinflammatory cascade: a mechanism for the pathogenesis of avian influenza H5N1 infection"},{"title3":"Hung IF, Wang To KK, Chan J, Chan KH, Yuen KY. ECCMID 2019. O0815 Treatment of severe influenza A infection with celecoxib. https://www.escmid.org. Accessed 14 Sep 2019"},{"title3":"Delayed oseltamivir plus sirolimus treatment attenuates H1N1 virus-induced severe lung injury correlated with repressed NLRP3 inflammasome activation and inflammatory cell infiltration"},{"title3":"Rapamycin adjuvant and exacerbation of severe influenza in an experimental mouse model"},{"title3":"Adjuvant treatment with a mammalian target of rapamycin inhibitor, sirolimus, and steroids improves outcomes in patients with severe H1N1 pneumonia and acute respiratory failure"},{"title3":"Simvastatin in the acute respiratory distress syndrome"},{"title3":"Acute respiratory distress syndrome subphenotypes and differential response to simvastatin: secondary analysis of a randomised controlled trial"},{"title3":"Hyperimmune IV immunoglobulin treatment: a multicenter double-blind randomized controlled trial for patients with severe 2009 influenza A(H1N1) infection"},{"title3":"Anti-influenza hyperimmune intravenous immunoglobulin for adults with influenza A or B infection (FLU-IVIG): a double-blind, randomised, placebo-controlled trial"},{"title3":"Anti-influenza immune plasma for the treatment of patients with severe influenza A: a randomised, double-blind, phase 3 trial"},{"title3":"Effect of vitamin c infusion on organ failure and biomarkers of inflammation and vascular injury in patients with sepsis and severe acute respiratory failure: the CITRIS-ALI Randomized clinical trial"},{"title3":"Influenza coinfection: be(a)ware of invasive aspergillosis"},{"title3":"Official ERS/ATS clinical practice guidelines: noninvasive ventilation for acute respiratory failure"},{"title3":"Critically ill patients with 2009 influenza A(H1N1) infection in Canada"},{"title3":"Risk factors for noninvasive ventilation failure in critically ill subjects with confirmed influenza infection"},{"title3":"Effectiveness of noninvasive positive pressure ventilation in the treatment of acute respiratory failure in severe acute respiratory syndrome"},{"title3":"Transmission of severe acute respiratory syndrome during intubation and mechanical ventilation"},{"title3":"Noninvasive ventilation in critically ill patients with the Middle East respiratory syndrome"},{"title3":"Effect of noninvasive ventilation delivered by helmet vs face mask on the rate of endotracheal intubation in patients with acute respiratory distress syndrome: a randomized clinical trial"},{"title3":"High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure"},{"title3":"High-flow nasal therapy in adults with severe acute respiratory infection: a cohort study in patients with 2009 influenza A/H1N1v"},{"title3":"Higher vs lower positive end-expiratory pressure in patients with acute lung injury and acute respiratory distress syndrome: systematic review and meta-analysis"},{"title3":"Writing Group for the Alveolar Recruitment for Acute Respiratory Distress Syndrome Trial I, Cavalcanti AB, Suzumura EA, Laranjeira LN, Paisani DM, Damiani LP, Guimaraes HP, Romano ER, Regenga MM, Taniguchi LNT, Teixeira C, Pinheiro de Oliveira R, Machado FR, Diaz-Quijano FA, Filho MSA, Maia IS, Caser EB, Filho WO, Borges MC, Martins PA, Matsui M, Ospina-Tascon GA, Giancursi TS, Giraldo-Ramirez ND, Vieira SRR, Assef M, Hasan MS, Szczeklik W, Rios F, Amato MBP, Berwanger O, Ribeiro de Carvalho CR, (2017) Effect of lung recruitment and titrated positive end-expiratory pressure (PEEP) vs low PEEP on Mortality in patients with acute respiratory distress syndrome: a randomized clinical trial. JAMA 318:1335-1345"},{"title3":"Experience with high frequency oscillation ventilation during the 2009 H1N1 influenza pandemic in Australia and New Zealand"},{"title3":"High-frequency oscillation in early acute respiratory distress syndrome"},{"title3":"High-frequency oscillation for acute respiratory distress syndrome"},{"title3":"Severity of hypoxemia and effect of high-frequency oscillatory ventilation in acute respiratory distress syndrome"},{"title3":"Prone positioning in severe acute respiratory distress syndrome"},{"title3":"A multicenter retrospective review of prone position ventilation (PPV) in treatment of severe human H7N9 avian flu"},{"title3":"Neuromuscular blockers in early acute respiratory distress syndrome"},{"title3":"Early neuromuscular blockade in the acute respiratory distress syndrome"},{"title3":"Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome"},{"title3":"Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome and posterior probability of mortality benefit in a post hoc bayesian analysis of a randomized clinical trial"},{"title3":"Referral to an extracorporeal membrane oxygenation center and mortality among patients with severe 2009 influenza A(H1N1)"},{"title3":"Extracorporeal membrane oxygenation for severe Middle East respiratory syndrome coronavirus"},{"title3":"National Heart L, Blood Institute Acute Respiratory Distress Syndrome Clinical Trials N, Wiedemann HP, Wheeler AP, Bernard GR, Thompson BT, Hayden D, deBoisblanc B, Connors AF, Jr., Hite RD, Harabin AL, (2006) Comparison of two fluid-management strategies in acute lung injury. N Engl J Med 354:2564-2575"},{"title3":"Right and left heart failure in severe H1N1 influenza A infection"},{"title3":"Myocardial injury and bacterial pneumonia contribute to the pathogenesis of fatal influenza B virus infection"},{"title3":"Acute myocardial infarction after laboratory-confirmed influenza infection"},{"title3":"Cardiac manifestations in patients with pandemic (H1N1) 2009 virus infection needing intensive care"},{"title3":"Successful treatment of novel H1N1 influenza related fulminant myocarditis with extracorporeal life support"},{"title3":"Aerosol generating procedures and risk of transmission of acute respiratory infections to healthcare workers: a systematic review"},{"title3":"N95 respirators vs medical masks for preventing influenza among health care personnel: a randomized clinical trial"},{"title3":"Surgical mask vs N95 respirator for preventing influenza among health care workers: a randomized trial"},{"title3":"A cluster randomised trial of cloth masks compared with medical masks in healthcare workers"},{"title3":"Situations leading to reduced effectiveness of current hand hygiene against infectious mucus from influenza virus-infected patients"},{"title3":"WHO public health research agenda for influenza. https://www.who.int/influenza/resources/research/en/. Last accessed Jan 4-2020"}]},{"title2":"Corticosteroid Therapy for Critically Ill Patients with Middle East Respiratory Syndrome","References":[]},{"title2":"Bulk and single-cell transcriptomics identify tobacco-use disparity in lung gene expression of ACE2, the receptor of 2019-nCov","References":[]},{"title2":"Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia","References":[]},{"title2":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","References":[{"title3":"Outbreak of pneumonia of unknown etiology in Wuhan China: the mystery and the miracle"},{"title3":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - the latest 2019 novel coronavirus outbreak in Wuhan, China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical management of severe acute respiratory infection when Novel coronavirus (nCoV) infection is suspected: interim guidance"},{"title3":"MERS, SARS and other coronaviruses as causes of pneumonia"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Clinical features predicting mortality risk in patients with viral pneumonia: the MuLBSTA score"},{"title3":"Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus"},{"title3":"Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human"},{"title3":"Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation"},{"title3":"Evidence for camel-to-human transmission of MERS coronavirus"},{"title3":"Surveillance of bat coronaviruses in Kenya identifies relatives of human coronaviruses NL63 and 229E and their recombination history"},{"title3":"Origin and evolution of pathogenic coronaviruses"},{"title3":"Fatal swine acute diarrhoea syndrome caused by an HKU2-related coronavirus of bat origin"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for the risk of human transmission"},{"title3":"Wuhan coronavirus has strong ability to infect humans. Press release"},{"title3":"From SARS to MERS, thrusting coronaviruses into the spotlight"},{"title3":"Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis"},{"title3":"Sex-based differences in susceptibility to severe acute respiratory syndrome coronavirus infection"},{"title3":"Sexual dimorphism in innate immunity"},{"title3":"Pathophysiology and burden of infection in patients with diabetes mellitus and peripheral vascular disease: focus on skin and soft-tissue infections"},{"title3":"Clinical findings in 111 cases of influenza A (H7N9) virus infection"},{"title3":"Clinical features of three avian influenza H7N9 virus-infected patients in Shanghai"},{"title3":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV"}]},{"title2":"CT Imaging and Differential Diagnosis of COVID-19","References":[{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR"},{"title3":"Radiographic and CT features of viral pneumonia"},{"title3":"Receptor recognition by novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS"},{"title3":"Spectrum of imaging findings in pulmonary infections. Part 1: Bacterial and viral"},{"title3":"The novel Chinese coronavirus (2019-nCoV) infections: challenges for fighting the storm"},{"title3":"Community-acquired pneumonia caused by Mycoplasma pneumoniae: how physical and radiological examination contribute to successful diagnosis"},{"title3":"Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: a data-driven analysis in the early phase of the outbreak"},{"title3":"Viral pneumonia requiring differentiation from acute and progressive diffuse interstitial lung diseases"},{"title3":"The fight against the 2019-nCoV outbreak: an arduous march has just begun"},{"title3":"Outbreak of pneumonia of unknown etiology in Wuhan, China: the mystery and the miracle"},{"title3":"Updated understanding of the outbreak of 2019 novel coronavirus (2019-nCoV) in Wuhan, China"}]},{"title2":"General Office of National Health Commission, General Office of National Administration of Traditional Chinese Medicine. Diagnostic and treatment protocol for Novel Coronavirus Pneumonia (Trial version 5) [EB/OL]. (2020-02-04) [2020-02-15]. http://www.gov.cn/zhengce/zhengceku/2020-02/05/content_5474791.htm.","References":[]},{"title2":"Clinical characteristics of 2019 novel coronavirus infection in China","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"The continuing 2019nCoV epidemic threat of novel coronaviruses to global health  the latest 2019 novel coronavirus outbreak in Wuhan, China"},{"title3":"Outbreak of pneumonia of unknown etiology in Wuhan China: the mystery and the miracle"},{"title3":"Pattern of early human-to-human transmission of Wuhan 2019 novel coronavirus (SARS-CoV-2), December 2019 to January 2020"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster [published online ahead of print, 2020 Jan 24]"},{"title3":"The latest situation of new coronavirus pneumonia as of 24:00 on February"},{"title3":"Statement on the second meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (SARS-CoV-2)"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Pathogenicity and transmissibility of SARS-CoV-2-A quick overview and comparison with other emerging viruses"},{"title3":"The epidemiology of severe acute respiratory syndrome in the 2003 Hong Kong epidemic: an analysis of all 1755 patients"},{"title3":"Notice on issuing a new coronavirus infected pneumonia diagnosis and treatment plan (Trial Version 5)"},{"title3":"Histopathologic changes and SARS-CoV-2 immunostaining in the lung of a patient with COVID-19"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan"},{"title3":"early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"30 January 2020 pneumonia epidemic situation of C SARS-CoV-2 infection in Hubei province, China-Hubei Provincial Health Committee"},{"title3":"4 February 2020 pneumonia epidemic situation of SARS-CoV-2 infection in Hubei province, China-Hubei Provincial Health Committee"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronaviruspneumonia in Wuhan, China: a descriptive study"},{"title3":"Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area"},{"title3":"MERS, SARS and other coronaviruses as causes of pneumonia"},{"title3":"Middle East respiratory syndrome"},{"title3":"Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China"},{"title3":"Eosinophils contribute to innate antiviral immunity and promote clearance of respiratory syncytial virus"},{"title3":"CT imaging features of 2019 novel coronavirus (SARS-CoV-2)"},{"title3":"Radiology of severe acute respiratory syndrome (SARS): the emerging pathologic-radiologic correlates of an emerging disease"},{"title3":"Thin-section CT 12 months after the diagnosis of severe acute respiratory syndrome in pediatric patients"},{"title3":"Optimizing diagnostic strategy for novel coronavirus pneumonia, a multi-center study in Eastern China"},{"title3":"Detection of Covid-19 in children in early January 2020 in Wuhan, China"},{"title3":"National Health Commission. Notice on issuing a nw coronary virus pneumonia diagnosis and treatment plan (Trial Version 7)"}]},{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: adescriptivestudy"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Lung CT image of a confirmed case of the 2019 novel coronavirus (2019-nCoV) infected pneumonia (With differential diagnosis of the SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Role of neutrophil to lymphocyte and monocyte to lymphocyte ratios in the diagnosis of bacterial infection in patients with fever"},{"title3":"Coronavirus infections-more than just the common cold"},{"title3":"The association between the neutrophil-to-lymphocyte ratio and mortality in critical illness: an observational cohort study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Monocyte/lymphocyte ratio as a better predictor of cardiovascular and all-cause mortality in hemodialysis patients: a prospective cohort study"},{"title3":"Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill"},{"title3":"Neutrophil-lymphocyte ratio as an early new marker in AIV-H7N9-infected patients: a retrospective study"}]},{"title2":"Isolation and Characterization of 2019-nCoV-like Coronavirus from Malayan","References":[]},{"title2":"A question of self-preservation: immunopathology in influenza virus infection","References":[]},{"title2":"Factors associated with psychosis among patients with severe acute respiratory syndrome a case-control study","References":[]},{"title2":"Clinical characteristics of 25 death cases with COVID-19: a retrospective review of medical records in a single medical center, Wuhan, China","References":[{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Structural basis for lipid binding and function by an evolutionarily conserved protein, serum amyloid A"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Importation and human-to-human transmission of a novel coronavirus in Vietnam"},{"title3":"'Hints' in the killer protein gasdermin D: unveiling the secrets of gasdermins driving cell death"},{"title3":"Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"C-reactive protein and inflammation: conformational changes affect function"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission"},{"title3":"A novel coronavirus from patients with pneumonia in China"}]},{"title2":"Factors of avascular necrosis of femoral head and osteoporosis in SARS patients' convalescence","References":[]},{"title2":"Case of the Index Patient Who Caused Tertiary Transmission of Coronavirus Disease 2019 in Korea: the Application of Lopinavir/Ritonavir for the Treatment of COVID-19 Pneumonia Monitored by Quantitative RT-PCR","References":[]},{"title2":"Viral Metagenomics Revealed Sendai Virus and Coronavirus Infection of Malayan Pangolins (Manis javanica)","References":[{"title3":"The phylogeny of living and extinct pangolins (mammalia, pholidota) and associated taxa: A morphology based analysis"},{"title3":"Immunohistochemical demonstration of keratins in the epidermal layers of the Malayan pangolin (Manis javanica), with remarks on the evolution of the integumental scale armour"},{"title3":"Complete Genome Sequence of Parainfluenza Virus 5 (PIV5) from a Sunda Pangolin (Manis javanica) in China"},{"title3":"Virome Analysis for Identification of Novel Mammalian Viruses in Bat Species from Chinese Provinces"},{"title3":"Faecal virome of cats in an animal shelter"},{"title3":"Exploring the virome of diseased horses"},{"title3":"A Metagenomics and Case-Control Study to Identify Viruses Associated with Bovine Respiratory Disease"},{"title3":"Faecal virome of healthy chickens reveals a large diversity of the eukaryote viral community, including novel circular ssDNA viruses"},{"title3":"Characterisation of the virome of tonsils from conventional pigs and from specific pathogen-free pigs"},{"title3":"Virome Diversity Correlates with Intestinal Microbiome Diversity in Adult Monozygotic Twins"},{"title3":"Further Defining the Human Virome using NGS: Identification of Redondoviridae"},{"title3":"Metagenomics for the discovery of novel human viruses"},{"title3":"Viral pathogen discovery"},{"title3":"Metagenomics and novel gene discovery: Promise and potential for novel therapeutics"},{"title3":"Diagnostic metagenomics: Potential applications to bacterial, viral and parasitic infections"},{"title3":"Metagenomics: Facts and artifacts, and computational challenges"},{"title3":"New tools for discovering and characterizing microbial diversity"},{"title3":"Detection of viruses in abalone tissue using metagenomics technology"},{"title3":"SOAPnuke: A MapReduce acceleration-supported software for integrated quality control and preprocessing of high-throughput sequencing data"},{"title3":"Fast and accurate short read alignment with Burrows-Wheeler transform"},{"title3":"MEGAHIT v1.0: A fast and scalable metagenome assembler driven by advanced methodologies and community practices"},{"title3":"Cd-hit: A fast program for clustering and comparing large sets of protein or nucleotide sequences"},{"title3":"MAFFT multiple sequence alignment software version 7: Improvements in performance and usability"},{"title3":"W-IQ-TREE: A fast online phylogenetic tool for maximum likelihood analysis"},{"title3":"Diversity and Evolution of Viral Pathogen Community in Cave Nectar Bats (Eonycteris spelaea)"},{"title3":"Virome analysis for identification of novel mammalian viruses in bats from Southeast China"},{"title3":"Fruit bats as reservoirs of Ebola virus"},{"title3":"Bats: Important reservoir hosts of emerging viruses"},{"title3":"Review of bats and SARS"},{"title3":"Studies of reservoir hosts for Marburg virus"},{"title3":"Novel Astroviruses in Insectivorous Bats"},{"title3":"Host Range, Prevalence, and Genetic Diversity of Adenoviruses in Bats"},{"title3":"Bats as a continuing source of emerging infections in humans"},{"title3":"Novel lyssavirus in Natterer's bat, Germany"},{"title3":"Complete Genome Analysis of Three Novel Picornaviruses from Diverse Bat Species"},{"title3":"Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats"},{"title3":"Identifying hendra virus diversity in pteropid bats"},{"title3":"A comparison of bats and rodents as reservoirs of zoonotic viruses: Are bats special?"},{"title3":"The Fecal Virome of Pigs on a High-Density Farm"},{"title3":"Diversity of viruses detected by deep sequencing in pigs from a common background"},{"title3":"Metagenomic analysis demonstrates the diversity of the fecal virome in asymptomatic pigs in East Africa"},{"title3":"Sendai virus, the mouse parainfluenza type 1: A longstanding pathogen that remains up-to-date"},{"title3":"A pneumotropic virus from mice causing hemagglutination"},{"title3":"Enzootic sendai virus infections in mouse breeder colonies within the United States"},{"title3":"A naturally occurring epizootic caused by Sendai virus in breeding and aging rodent colonies. I. Infection in the mouse"},{"title3":"Natural history of sendai virus infection in mice"},{"title3":"Isolation and characterization of novel bat paramyxovirus B16-40 potentially belonging to the proposed genus Shaanvirus"},{"title3":"Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus"},{"title3":"Coronaviridae: The viruses and their replication"},{"title3":"Characterization of a coronavirus isolated from a diarrheic foal"},{"title3":"Hospital outbreak of middle east respiratory syndrome coronavirus"},{"title3":"Co-circulation of three camel coronavirus species and recombination of MERS-CoVs in Saudi Arabia"},{"title3":"Bats Are Natural Reservoirs of SARS-Like Coronaviruses"},{"title3":"Bats, civets and the emergence of SARS"}]},{"title2":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding","References":[{"title3":"Epidemiology, genetic recombination, and pathogenesis of coronaviruses"},{"title3":"Coronavirus avian infectious bronchitis virus"},{"title3":"Pathogenicity of turkey coronavirus in turkeys and chickens"},{"title3":"Fatal swine acute diarrhoea syndrome caused by an HKU2-related coronavirus of bat origin"},{"title3":"Severe acute respiratory syndrome"},{"title3":"SARS: epidemiology"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"A dynamic compartmental model for the Middle East respiratory syndrome outbreak in the Republic of Korea: a retrospective analysis on control interventions and superspreading events"},{"title3":"The clinical and virological features of the first imported case causing MERS-CoV outbreak in South Korea, 2015"},{"title3":"A novel coronavirus genome identified in a cluster of pneumonia cases:Wuhan, China 2019-2020"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Two-tube multiplex real-time reverse transcription PCR to detect six human coronaviruses"},{"title3":"Fast and accurate short read alignment with Burrows-Wheeler transform"},{"title3":"RAPSearch2: a fast and memory-efficient protein similarity search tool for next-generation sequencing data"},{"title3":"Human infection with a novel, highly pathogenic avian influenza A (H5N6) virus: virological and clinical findings"},{"title3":"CDD/SPARCLE: functional classification of proteins via subfamily domain architectures"},{"title3":"Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination"},{"title3":"Parallelization of MAFFT for large-scale multiple sequence alignments"},{"title3":"RAxML version 8: a tool for phylogenetic analysis and post-analysis of large phylogenies"},{"title3":"Genomic characterization and infectivity of a novel SARS-like coronavirus in Chinese bats"},{"title3":"Structure, function, and evolution of coronavirus spike proteins"},{"title3":"Bat-to-human: spike features determining 'host jump' of coronaviruses SARS-CoV, MERS-CoV, and beyond"},{"title3":"MERS-CoV spike protein: targets for vaccines and therapeutics"},{"title3":"Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine"},{"title3":"Evidence for a common evolutionary origin of coronavirus spike protein receptor-binding subunits"},{"title3":"Structure of SARS coronavirus spike receptor-binding domain complexed with receptor"},{"title3":"Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26"},{"title3":"Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4"},{"title3":"Bat origins of MERS-CoV supported by bat coronavirus HKU4 usage of human receptor CD26"},{"title3":"SWISS-MODEL: homology modelling of protein structures and complexes"},{"title3":"Structure of severe acute respiratory syndrome coronavirus receptor-binding domain complexed with neutralizing antibody"},{"title3":"Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China"},{"title3":"Middle East respiratory syndrome coronavirus infection in dromedary camels in Saudi Arabia"},{"title3":"Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin"}]},{"title2":"The Effectiveness of Convalescent Plasma and Hyperimmune Immunoglobulin for the Treatment of Severe Acute Respiratory Infections of Viral Etiology: A Systematic Review and Exploratory Meta-analysis","References":[{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV):update (26 May 2014)"},{"title3":"Clinical management of severe acute respiratory infections when novel coronavirus is suspected: what to do and what not to do"},{"title3":"Treatment of MERS-CoV: decision support tool v.1.0"},{"title3":"State of knowledge and data gaps of middle east respiratory syndrome coronavirus (MERS-CoV) in humans"},{"title3":"Hyperimmune iv immunoglobulin treatment: A multicenter double-blind randomized controlled trial for patients with severe 2009 influenza a(H1N1) infection"},{"title3":"Treatment of severe acute respiratory syndrome"},{"title3":"SARS: systematic review of treatment effects"},{"title3":"Experience of using convalescent plasma for severe acute respiratory syndrome among healthcare workers in a Taiwan hospital"},{"title3":"The management of coronavirus infections with particular reference to SARS"},{"title3":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement"},{"title3":"Middle East Respiratory Syndrome Coronavirus (MERS-CoV) and the effectiveness of convalescent plasma for the treatment of severe acute respiratory infections of viral aetiology: a systematic review. PROSPERO 2013CRD42013005091"},{"title3":"Cochrane handbook for systematic reviews of interventions. Version 5.1.0. Updated March 2011"},{"title3":"The Newcastle-Ottawa Scale (NOS) for assessing the quality of non-randomised studies in meta-analyses"},{"title3":"Influenza vaccination for immunocompromised patients: systematic review and meta-analysis from a public health policy perspective"},{"title3":"Use of serum in the treatment of influenza-pneumonia"},{"title3":"Treatment of influenza with injections of blood from convalescents"},{"title3":"Treatment of influenza pneumonia with serum from convalescents"},{"title3":"Treatment of influenza pneumonia by use of convalescent human serum"},{"title3":"Meta-analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment?"},{"title3":"Clinical research during a public health emergency: a systematic review of severe pandemic influenza management"},{"title3":"Successful treatment of avian influenza with convalescent plasma"},{"title3":"Convalescent plasma for prophylaxis and treatment of severe pandemic influenza A (H1N1) 2009 infection: Case reports"},{"title3":"Treatment of severe acute respiratory syndrome with convalescent plasma"},{"title3":"Treatment with convalescent plasma for influenza A (H5N1) infection"},{"title3":"Clinical characteristics and therapeutic experience of case of severe highly pathogenic A/H5N1 avian influenza with bronchopleural fistula"},{"title3":"Letter to the editor"},{"title3":"Treatment of severe acute respiratory syndrome with convalescent plasma, author reply"},{"title3":"Hong Kong's experience on the use of extracorporeal membrane oxygenation for the treatment of influenza A (H1N1)"},{"title3":"Use of convalescent plasma therapy in SARS patients in Hong Kong"},{"title3":"Epidemiologic features, clinical diagnosis and therapy of first cluster of patients with severe acute respiratory syndrome in Beijing area"},{"title3":"Treatment of influenzal pneumonia with plasma of convalescent patients"},{"title3":"Treatment of influenzal pneumonia by the use of convalescent human serum"},{"title3":"Human serum in influenza"},{"title3":"Clinical characteristics of 26 human cases of highly pathogenic avian 36]influenza A (H5N1) virus infection in China"},{"title3":"Retrospective study on collecting convalescent donors's plasma in treatment of patients with pandemic influenza A (H1N1) virus infection"},{"title3":"Human serum in the treatment of influenza bronchopneumonia"},{"title3":"Convalescent serum in treatment of influenza"},{"title3":"Convalescent serum in the prevention and treatment of influenza"},{"title3":"Plasma therapy in influenza"},{"title3":"Report of influenza treated with serum from recovered cases"},{"title3":"Convalescent serum in the treatment of influenza pneumonia"},{"title3":"The use of the serum of convalescents in the treatment of influenza pneumonia: A summary of the results in a series of one hundred and one cases"},{"title3":"Advances in clinical diagnosis and treatment of severe acute respiratory syndrome"},{"title3":"Retrospective comparison of convalescent plasma with continuing high-dose methylprednisolone treatment in SARS patients"},{"title3":"Serum treatment of postinfluenzal bronchopneumonia"},{"title3":"Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A (H1N1) 2009 virus infection"},{"title3":"Treatment of Severe Pandemic Influenza A/H1N1 Infection"},{"title3":"Convalescent transfusion for pandemic influenza: preparing blood banks for a new plasma product?"}]},{"title2":"The effect of corticosteroids on mortality of patients with influenza pneumonia: a systematic review and meta-analysis","References":[{"title3":"The effect of corticosteroids on mortality of patients with influenza pneumonia: a systematic review and meta-analysis"}]},{"title2":"The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China","References":[{"title3":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - the latest 2019 novel coronavirus outbreak in Wuhan, China"}]},{"title2":"Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury","References":[]},{"title2":"The impact of transmission control measures during the first 50 days of the COVID-19","References":[]},{"title2":"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China","References":[]},{"title2":"World Health Organization, 2019: World Health Organization. Middle East respiratory syndrome coronavirus (MERS-CoV) [EB/OL]. (2019-11-30) [2020-02-18]. https://www.who.int/emergencies/mers-cov/en/.","References":[]},{"title2":"Glucocorticoid-induced diabetes in severe acute respiratory syndrome: the impact of high dosage and duration of methylprednisolone therapy","References":[]},{"title2":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission","References":[{"title3":"Transmission and evolution of the Middle East respiratory syndrome coronavirus in Saudi Arabia: a descriptive genomic study"},{"title3":"Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus"},{"title3":"Evidence for a common evolutionary origin of coronavirus spike protein receptor-binding subunits"},{"title3":"Structure of SARS coronavirus spike receptor-binding domain complexed with receptor"},{"title3":"ff14SB: improving the accuracy of protein side chain and backbone parameters from ff99SB"},{"title3":"Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC"},{"title3":"SWISSMODEL: an automated protein homology-modeling server"},{"title3":"GISAID: Global initiative on sharing all influenza data:from vision to reality"}]},{"title2":"A Novel Coronavirus from Patients with Pneumonia in China, 2019","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Inferring the hosts of coronavirus using dual statistical models based on nucleotide composition"},{"title3":"Importation and human-to-human transmission of a novel coronavirus in Vietnam"},{"title3":"2019 novel coronavirus (2019-nCoV) outbreak: a new challenge"},{"title3":"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan"},{"title3":"Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China"},{"title3":"Novel Wuhan (2019-nCoV) coronavirus"},{"title3":"Severe acute respiratory syndrome coronavirus phylogeny: toward consensus"},{"title3":"Diagnosis and treatment of new coronavirus pneumonia (trial version 7) [J / OL]. Tianjin J Tradit Chin Med. 2020;1-5. http://kns.cnki.net/kcms/detail/12.1349.R.20200304.1638.006.html. Accessed 3 June 2020."},{"title3":"Clinical outcome of standardized oxygen therapy nursing strategy in COVID-19"},{"title3":"Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission"},{"title3":"Angiotensin-converting enzyme 2: a functional receptor for SARS coronavirus"},{"title3":"Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection"},{"title3":"High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa"},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis"},{"title3":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation"},{"title3":"Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways"},{"title3":"Significant changes of peripheral T lymphocyte subsets in patients with severe acute respiratory syndrome"},{"title3":"Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV"},{"title3":"Lactate dehydrogenase and C-reactive protein as predictors of respiratory failure in CoVID-19 patients"},{"title3":"Lactate dehydrogenase, an independent risk factor of severe COVID-19 patients: a retrospective and observational study"},{"title3":"C-reactive protein correlates with computed tomographic findings and predicts severe COVID-19 early"},{"title3":"Eosinopenia and elevated C-reactive protein facilitate triage of COVID-19 patients in fever clinic: a retrospective case-control study"},{"title3":"Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China"},{"title3":"Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19)"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Human ipsc-derived cardiomyocytes are susceptible to Sars-Cov-2 infection"},{"title3":"Cardiovascular complications in COVID-19"},{"title3":"COVID-19 pandemic and troponin: indirect myocardial injury, myocardial inflammation or myocarditis?"},{"title3":"Endothelial cell infection and endotheliitis in COVID-19"}]}]},{"title1":"Epidemiological, clinical characteristics of cases of SARS-CoV-2 infection with abnormal imaging findings","References":[{"title2":"Severe acute respiratory syndrome-related coronavirus: the species and its viruses:a statement of the Coronavirus Study Group","References":[]},{"title2":"The next big threat to global health? 2019 novel coronavirus (2019-nCoV): what advice can we give to travellers? - interim recommendations January 2020, from the Latin-American Society for Travel Medicine (SLAMVI)","References":[{"title3":"Outbreak of pneumonia of unknown etiology in wuhan China: the mystery and the miracle"},{"title3":"Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin"},{"title3":"Wuhan airport. Wuhan airport"},{"title3":"GRU airport"},{"title3":"Boletines operacionales"},{"title3":"Global health concern stirred by emerging viral infections"},{"title3":"Recent advances in the detection of respiratory virus infection in humans"},{"title3":"The structure and functions of coronavirus genomic 3' and 5' ends"},{"title3":"Emerging coronaviruses: genome structure, replication, and pathogenesis"},{"title3":"MERS, SARS and other coronaviruses as causes of pneumonia"},{"title3":"Travel implications of emerging coronaviruses: SARS and MERS-CoV"},{"title3":"The severe acute respiratory syndrome: impact on travel and tourism"},{"title3":"Asymptomatic Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection: extent and implications for infection control: a systematic review"},{"title3":"MERS-CoV as an emerging respiratory illness: a review of prevention methods"},{"title3":"Preparedness and proactive infection control measures against the emerging Wuhan coronavirus pneumonia in China"},{"title3":"Why snakes probably aren't spreading the new China virus"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Novel coronavirus (2019-nCoV) - situation report - 4 - 24 january 2020"},{"title3":"Novel coronavirus (2019-nCoV) - situation report - 7 - 27 january 2020"},{"title3":"Statement on the meeting of the international health Regulations (2005) emergency committee regarding the outbreak of novel coronavirus (2019-nCoV)"},{"title3":"The 2014 FIFA World Cup: communicable disease risks and advice for visitors to Brazil--a review from the Latin American Society for Travel Medicine (SLAMVI)"},{"title3":"The 2019 Pan American games: communicable disease risks and travel medicine advice for visitors to Peru - recommendations from the Latin American Society for Travel Medicine (SLAMVI)"},{"title3":"Risk assessment of dengue autochthonous infections in Tokyo during summer, especially in the period of the 2020 olympic games"}]},{"title2":"Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China","References":[]},{"title2":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","References":[{"title3":"Outbreak of pneumonia of unknown etiology in Wuhan China: the mystery and the miracle"},{"title3":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - the latest 2019 novel coronavirus outbreak in Wuhan, China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical management of severe acute respiratory infection when Novel coronavirus (nCoV) infection is suspected: interim guidance"},{"title3":"MERS, SARS and other coronaviruses as causes of pneumonia"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Clinical features predicting mortality risk in patients with viral pneumonia: the MuLBSTA score"},{"title3":"Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus"},{"title3":"Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human"},{"title3":"Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation"},{"title3":"Evidence for camel-to-human transmission of MERS coronavirus"},{"title3":"Surveillance of bat coronaviruses in Kenya identifies relatives of human coronaviruses NL63 and 229E and their recombination history"},{"title3":"Origin and evolution of pathogenic coronaviruses"},{"title3":"Fatal swine acute diarrhoea syndrome caused by an HKU2-related coronavirus of bat origin"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for the risk of human transmission"},{"title3":"Wuhan coronavirus has strong ability to infect humans. Press release"},{"title3":"From SARS to MERS, thrusting coronaviruses into the spotlight"},{"title3":"Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis"},{"title3":"Sex-based differences in susceptibility to severe acute respiratory syndrome coronavirus infection"},{"title3":"Sexual dimorphism in innate immunity"},{"title3":"Pathophysiology and burden of infection in patients with diabetes mellitus and peripheral vascular disease: focus on skin and soft-tissue infections"},{"title3":"Clinical findings in 111 cases of influenza A (H7N9) virus infection"},{"title3":"Clinical features of three avian influenza H7N9 virus-infected patients in Shanghai"},{"title3":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV"}]},{"title2":"Treatment of severe acute respiratory syndrome with glucosteroids: the Guangzhou experience","References":[{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Treatment of severe acute respiratory syndrome"},{"title3":"Description and clinical treatment of an early outbreak of severe acute respiratory syndrome (SARS) in Guangzhou, PR China"},{"title3":"Development of a standard treatment protocol for severe acute respiratory syndrome"},{"title3":"High dose pulse versus non-pulse corticosteroid regimens in severe acute respiratory syndrome"},{"title3":"Use of glucocorticoid in treatment of severe acute respiratory syndrome cases"},{"title3":"Glucocorticoid-induced diabetes in severe acute respiratory syndrome: the impact of high dosage and duration of methylprednisolone therapy"},{"title3":"Severe acute respiratory syndrome: report of treatment and outcome after a major outbreak"},{"title3":"Management and prevention of SARS in China"},{"title3":"Medical treatment of viral pneumonia including SARS in immunocompetent adult"},{"title3":"SARS: pharmacotherapy"},{"title3":"High dose intravenous methylprednisolone in the treatment of severe acute respiratory syndrome"},{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"The clinical characteristics of secondary infections of lower respiratory tract in severe acute respiratory syndrome"},{"title3":"Nosocomial infections and nosocomial pneumonia"},{"title3":"Chinese Medical Association. Guidelines for management of atypical pneumonia (SARS)"},{"title3":"Comparative study of clinical characteristics and prognosis of clinically diagnosed SARS patients with positive and negative serum SARS coronavirus-specific antibodies test"},{"title3":"A preliminary study of serum antibody level in SARS patients"},{"title3":"Severe acute respiratory syndrome (SARS): a challenge for diagnosis and treatment"},{"title3":"Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February, 2003"},{"title3":"Glucocorticoid in the treatment of severe acute respiratory syndrome patients: a preliminary report"},{"title3":"Effects of early corticosteroid treatment on plasma SARS-associated Coronavirus RNA concentrations in adult patients"},{"title3":"Coronavirus-positive nasopharyngeal aspirate as predictor for severe acute respiratory syndrome mortality"},{"title3":"High dose methylprednisolone in a porcine model of ARDS induced by endotoxemia"},{"title3":"Ineffectiveness of high dose methylprednisolone in preventing parenchymal lung injury and improving mortality in patients with septic shock"},{"title3":"High dose corticosteroids in patients with the adult respiratory distress syndrome"},{"title3":"Prolonged methylprednisolone treatment suppresses systemic inflammation in patients with unresolving acute respiratory distress syndrome"},{"title3":"Respiratory and cadiovascular management of septic ALI-ARDS and shock"},{"title3":"Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS: plasma IL-1 beta and IL-6 levels are consistent and efficient predictors of outcome over time"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"Characterization of cytokine/chemokine profiles of severe acute respiratory syndrome"},{"title3":"Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome"},{"title3":"Prolonged disturbances ofin vitrocytokine production in patients with severe acute respiratory syndrome treated with ribavirin and steroids"},{"title3":"Report on the investigation of lower extremity osteonecrosis with magnetic resonance imaging in recovered severe acute respiratory syndrome in Guangzhou"},{"title3":"Osteonecrosis of hip and knee in patients with severe acute respiratory syndrome treated with steroids"},{"title3":"Factors of avascular necrosis of femoral head and osteoporosis in SARS patients' convalescence"},{"title3":"Avascular necrosis of bone in severe acute respiratory syndrome"}]},{"title2":"Human disease from influenza A (H5N1), Thailand, 2004","References":[{"title3":"Outbreak of avian influenza A (H5N1) virus infection in Hong Kong in 1997."},{"title3":"Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness."},{"title3":"Risk of influenza A (H5N1) infection among poultry workers, Hong Kong, 1997-1998."},{"title3":"Interspecies transmission of influenza viruses: H5N1 virus and a Hong Kong SAR perspective."},{"title3":"Influenza."},{"title3":"Human infection with influenza H9N2."},{"title3":"Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome."},{"title3":"Avian influenza A (H5N1):situation (poultry) in Asia as at 2 March 2004: need for a long-term response, comparison with previous outbreaks."},{"title3":"Avian influenza A (H5N1) in 10 patients in Vietnam."},{"title3":"Cases of influenza A (H5N1):Thailand, 2004."},{"title3":"Outbreaks of avian influenza A (H5N1) in Asia and interim recommendations for evaluation and reporting of suspected cases:United States, 2004."},{"title3":"Development of a real-time reverse transcriptase PCR assay for type A influenza virus and the avian H5 and H7 hemagglutinin subtypes."},{"title3":"Childhood pneumonia: clinical aspects associated with hospitalization or death."},{"title3":"Factors associated with death among adults &lt;55 years of age hospitalized for community-acquired pneumonia."},{"title3":"Pneumonia surveillance in Thailand: current practice and future needs."},{"title3":"Antigenic differences between H5N1 human influenza viruses isolated in 1997 and 2003."},{"title3":"Avian influenza in Hong Kong 1997-2002."},{"title3":"Reemerging H5N1 influenza viruses in Hong Kong in 2002 are highly pathogenic to ducks."},{"title3":"Pathogenicity of a Hong Kong-origin H5N1 highly pathogenic avian influenza virus for emus, geese, ducks, and pigeons."},{"title3":"Infectious diseases. Avian influenza makes a comeback, reviving pandemic worries."},{"title3":"Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus."},{"title3":"Risk of influenza A (H5N1) infection among health care workers exposed to patients with influenza A (H5N1), Hong Kong."},{"title3":"Antibody response in individuals infected with avian influenza A (H5N1) viruses and detection of anti-H5 antibody among household and social contacts."},{"title3":"H5N1) in Hong Kong: an overview."},{"title3":"The evolution of H5N1 influenza viruses in ducks in southern China."}]},{"title2":"CT imaging features of 2019 Novel Coronavirus (2019-nCoV)","References":[{"title3":"Novel Coronavirus - China. World Health Organization"},{"title3":"Novel Coronavirus (2019-nCoV). World Health Organization"},{"title3":"Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003. World Health Organization"},{"title3":"Middle East respiratory syndrome Coronavirus (MERS-CoV). World Health Organization"},{"title3":"Situation report - 8. World Health Organization"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Fleischner Society: glossary of terms for thoracic imaging"},{"title3":"Radiographic and CT Features of Viral Pneumonia"},{"title3":"Severe acute respiratory syndrome: temporal lung changes at thin-section CT in 30 patients"},{"title3":"Severe acute respiratory syndrome: radiographic appearances and pattern of progression in 138 patients"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV) infection: chest CT findings"},{"title3":"Middle East respiratory syndrome-Coronavirus infection: a case report of serial computed tomographic findings in a young male patient"},{"title3":"About 2019 Novel Coronavirus (2019-nCoV). Centers for Disease Control and Prevention"},{"title3":"Radiologic pattern of disease in patients with severe acute respiratory syndrome: the Toronto experience"}]},{"title2":"Middle east respiratory syndrome coronavirus: what does a radiologist need to know?","References":[]},{"title2":"Human coronavirus: host-pathogen interaction","References":[]},{"title2":"The digestive system is a potential route of 2019-nCov infection: a bioinformatics analysis based on single-cell transcriptomes","References":[]},{"title2":"First case of 2019 novel coronavirus in the United States","References":[{"title3":"Pneumonia of unknown cause : China."},{"title3":"Novel coronavirus : China."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China."},{"title3":"2019 Novel coronavirus, Wuhan, China: 2019-nCoV situation summary."},{"title3":"Importation and human-to-human transmission of a novel coronavirus in Vietnam."},{"title3":"Wuhan coronavirus (2019-nCoV) global cases"},{"title3":"Interim guidance for healthcare professionals: criteria to guide evaluation of patients under investigation (PUI) for 2019-nCoV."},{"title3":"Infection control. 2019 Novel coronavirus, Wuhan, China."},{"title3":"A randomized, controlled trial of ebola virus disease therapeutics."},{"title3":"Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV."},{"title3":"Interim guidelines for collecting, handling, and testing clinical specimens from patients under investigation (PUIs) for 2019 novel coronavirus (2019-nCoV)."},{"title3":"Real-time RT-PCR panel for detection 2019-novel coronavirus."},{"title3":"2019-novel coronavirus (2019-nCoV) real-time rRT-PCR panel primers and probes."},{"title3":"Information for laboratories. 2019 novel coronavirus, Wuhan, China."},{"title3":"GenBank overview"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019."},{"title3":"Novel coronavirus outbreak 2020"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study."}]},{"title2":"Pulmonary response to major injury","References":[]},{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: adescriptivestudy"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Lung CT image of a confirmed case of the 2019 novel coronavirus (2019-nCoV) infected pneumonia (With differential diagnosis of the SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Role of neutrophil to lymphocyte and monocyte to lymphocyte ratios in the diagnosis of bacterial infection in patients with fever"},{"title3":"Coronavirus infections-more than just the common cold"},{"title3":"The association between the neutrophil-to-lymphocyte ratio and mortality in critical illness: an observational cohort study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Monocyte/lymphocyte ratio as a better predictor of cardiovascular and all-cause mortality in hemodialysis patients: a prospective cohort study"},{"title3":"Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill"},{"title3":"Neutrophil-lymphocyte ratio as an early new marker in AIV-H7N9-infected patients: a retrospective study"}]},{"title2":"Clinical factors predictive of pneumonia caused by pandemic 2009 H1N1 influenza virus","References":[]},{"title2":"Chest CT findings in 2019 novel coronavirus (2019-nCoV) Infections from Wuhan, China: key points for the radiologist","References":[{"title3":"A Novel Coronavirus from Patients with Pneumonia in China"},{"title3":"Geneva, Switzerland: World Health Organization"},{"title3":"Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses"},{"title3":"Origin and evolution of pathogenic coronaviruses"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"CT Imaging of the 2019 Novel Coronavirus (2019-nCoV) Pneumonia"},{"title3":"CT imaging features of 2019 novel coronavirus (2019-nCoV)"},{"title3":"High-resolution CT findings of severe acute respiratory syndrome at presentation and after admission"},{"title3":"SARS: imaging of severe acute respiratory syndrome"},{"title3":"Severe acute respiratory syndrome: temporal lung changes at thin-section CT in 30 patients"},{"title3":"Acute Middle East Respiratory Syndrome Coronavirus: Temporal Lung Changes Observed on the Chest Radiographs of 55 Patients"},{"title3":"CT correlation with outcomes in 15 patients with acute Middle East respiratory syndrome coronavirus"},{"title3":"Acute respiratory distress syndrome: CT abnormalities at long-term follow-up"},{"title3":"Acute respiratory distress syndrome: imaging of the injured lung"}]},{"title2":"Response to the emerging novel coronavirus outbreak","References":[]},{"title2":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding","References":[{"title3":"Epidemiology, genetic recombination, and pathogenesis of coronaviruses"},{"title3":"Coronavirus avian infectious bronchitis virus"},{"title3":"Pathogenicity of turkey coronavirus in turkeys and chickens"},{"title3":"Fatal swine acute diarrhoea syndrome caused by an HKU2-related coronavirus of bat origin"},{"title3":"Severe acute respiratory syndrome"},{"title3":"SARS: epidemiology"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"A dynamic compartmental model for the Middle East respiratory syndrome outbreak in the Republic of Korea: a retrospective analysis on control interventions and superspreading events"},{"title3":"The clinical and virological features of the first imported case causing MERS-CoV outbreak in South Korea, 2015"},{"title3":"A novel coronavirus genome identified in a cluster of pneumonia cases:Wuhan, China 2019-2020"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Two-tube multiplex real-time reverse transcription PCR to detect six human coronaviruses"},{"title3":"Fast and accurate short read alignment with Burrows-Wheeler transform"},{"title3":"RAPSearch2: a fast and memory-efficient protein similarity search tool for next-generation sequencing data"},{"title3":"Human infection with a novel, highly pathogenic avian influenza A (H5N6) virus: virological and clinical findings"},{"title3":"CDD/SPARCLE: functional classification of proteins via subfamily domain architectures"},{"title3":"Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination"},{"title3":"Parallelization of MAFFT for large-scale multiple sequence alignments"},{"title3":"RAxML version 8: a tool for phylogenetic analysis and post-analysis of large phylogenies"},{"title3":"Genomic characterization and infectivity of a novel SARS-like coronavirus in Chinese bats"},{"title3":"Structure, function, and evolution of coronavirus spike proteins"},{"title3":"Bat-to-human: spike features determining 'host jump' of coronaviruses SARS-CoV, MERS-CoV, and beyond"},{"title3":"MERS-CoV spike protein: targets for vaccines and therapeutics"},{"title3":"Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine"},{"title3":"Evidence for a common evolutionary origin of coronavirus spike protein receptor-binding subunits"},{"title3":"Structure of SARS coronavirus spike receptor-binding domain complexed with receptor"},{"title3":"Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26"},{"title3":"Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4"},{"title3":"Bat origins of MERS-CoV supported by bat coronavirus HKU4 usage of human receptor CD26"},{"title3":"SWISS-MODEL: homology modelling of protein structures and complexes"},{"title3":"Structure of severe acute respiratory syndrome coronavirus receptor-binding domain complexed with neutralizing antibody"},{"title3":"Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China"},{"title3":"Middle East respiratory syndrome coronavirus infection in dromedary camels in Saudi Arabia"},{"title3":"Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin"}]},{"title2":"Prevalence and clinical features of pneumonia in patients with laboratory-confirmed pandemic influenza A H1N1 2009 infection in South Korea","References":[]},{"title2":"Novel coronavirus: From discovery to clinical diagnostics","References":[{"title3":"Multicenter evaluation of the ePlex respiratory pathogen panel for the detection of viral and bacterial respiratory tract pathogens in nasopharyngeal swabs"},{"title3":"Comparing Luminex NxTAG-respiratory pathogen panel and RespiFinder-22 for multiplex detection of respiratory pathogens"},{"title3":"Human coronavirus: host-pathogen interaction"},{"title3":"Multiplex PCR system for the rapid diagnosis of respiratory virus infection: systematic review and meta-analysis"},{"title3":"Molecular epidemiology, evolution and phylogeny of SARS coronavirus"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV): A review"},{"title3":"Global epidemiology of bat coronaviruses"},{"title3":"China Novel Coronavirus Investigating and Research Team. A novel coronavirus from patients with pneumonia in China, 2019"}]},{"title2":"Acute respiratory distress syndrome: the Berlin definition","References":[]},{"title2":"Risk factors of A/H1N1 etiology in pneumonia and its impact on mortality","References":[]},{"title2":"Gastrointestinal manifestations among Chilean patients infected with novel influenza A (H1N1) 2009 virus","References":[]},{"title2":"A novel coronavirus genome identified in a cluster of pneumonia cases:Wuhan, China 2019-2020","References":[{"title3":"From &quot;A&quot;IV to &quot;Z&quot;IKV: attacks from emerging and Re-emerging  pathogens"},{"title3":"MAFFT multiple sequence alignment software version 7: improvements in performance and usability"},{"title3":"A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood"}]},{"title2":"H1N1 infection and the kidney in critically ill patients","References":[]},{"title2":"Receptor recognition by novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS","References":[{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"Evidence of airborne transmission of the severe acute respiratory syndrome virus"},{"title3":"The genome sequence of the SARS-associated coronavirus"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"Isolation and characterization of viruses related to the SARS coronavirus from animals in Southern China"},{"title3":"Laboratory diagnosis of four recent sporadic cases of community-acquired SARS, Guangdong Province, China"},{"title3":"Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human"},{"title3":"Mechanisms of zoonotic severe acute respiratory syndrome coronavirus host range expansion in human airway epithelium"},{"title3":"Natural mutations in the receptor binding domain of spike glycoprotein determine the reactivity of cross-neutralization between palm civet coronavirus and severe acute respiratory syndrome coronavirus"},{"title3":"Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus"},{"title3":"Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor"},{"title3":"Origin and evolution of pathogenic coronaviruses"},{"title3":"Receptor recognition and cross-species infections of SARS coronavirus"},{"title3":"Animal origins of the severe acute respiratory syndrome coronavirus: insight from ACE2-S-protein interactions"},{"title3":"Coronaviruses post-SARS: update on replication and pathogenesis"},{"title3":"Structure, function, and evolution of coronavirus spike proteins"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"Receptor recognition mechanisms of coronaviruses: a decade of structural studies"},{"title3":"Efficient replication of severe acute respiratory syndrome coronavirus in mouse cells is limited by murine angiotensin-converting enzyme 2"},{"title3":"Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2"},{"title3":"Lethal infection of K18-hACE2 mice infected with severe acute respiratory syndrome coronavirus"},{"title3":"Retroviruses pseudotyped with the severe acute respiratory syndrome coronavirus spike protein efficiently infect cells expressing angiotensin-converting enzyme 2"},{"title3":"Identification of two critical amino acid residues of the severe acute respiratory syndrome coronavirus spike protein for its variation in zoonotic tropism transition via a double substitution strategy"},{"title3":"Structural analysis of major species barriers between humans and palm civets for severe acute respiratory syndrome coronavirus infections"},{"title3":"Structure of SARS coronavirus spike receptor-binding domain complexed with receptor"},{"title3":"Mechanisms of host receptor adaptation by severe acute respiratory syndrome coronavirus"},{"title3":"Receptor usage and cell entry of bat coronavirus HKU4 provide insight into bat-to-human transmission of MERS coronavirus"},{"title3":"Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC"},{"title3":"Angiotensin-converting enzyme 2 (ACE2) proteins of different bat species confer variable susceptibility to SARS-CoV entry"},{"title3":"Functional assessment of cell entry and receptor usage for lineage B beta-coronaviruses, including 2019-nCoV"},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"Coot: model-building tools for molecular graphics"},{"title3":"Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega"}]},{"title2":"Severe acute respiratory syndrome: radiographic appearances and pattern of progression in 138 patients","References":[]},{"title2":"Novel coronavirus (2019-nCoV) situation report","References":[]},{"title2":"Chest CT for Typical 2019-nCoV pneumonia: relationship to negative RT-PCR testing","References":[]},{"title2":"Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2","References":[{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"Quality Appraisal of Case Series Studies Checklist"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"CT imaging features of 2019 novel coronavirus (2019-nCoV)"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province"},{"title3":"Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China"},{"title3":"Computed tomography features of patients with novel coronavirus pneumonia"},{"title3":"Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury (Chinese)"},{"title3":"CT features of patients with imported 2019-nCoV-pneumonia"},{"title3":"Preliminary explore on CT characteristics of coronavirus disease 2019 (COVID-19)"},{"title3":"Initial CT findings and temporal changes in patients with the novel coronavirus pneumonia (2019-nCoV): a study of 63 patients in Wuhan, China"},{"title3":"The epidemiological and clinical characteristics of 2019 novel coronavirus infection in Changsha, China"},{"title3":"Time course of lung changes on chest CT during recovery from 2019 novel coronavirus (COVID-19) pneumonia"},{"title3":"Clinical features of 2019 novel coronavirus pneumonia in the early stage from a fever clinic in Beijing"},{"title3":"Analysis of CT features of 15 children with 2019 novel coronavirus infection"},{"title3":"Retracted: Clinical and epidemiological characteristics of 34 children with 2019 novel coronavirus infection in Shenzhen"},{"title3":"The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China"},{"title3":"Chest CT performance and clinical characteristics of coronavirus disease 2019 (COVID-19)"},{"title3":"Clinical and epidemiological characteristics of 26 patients dia gnosed with novel coronavirus pneumonia"},{"title3":"Wang K, Kang SR, Tian RH, et al. CT characteristic appearances of patients with novel coronavirus pneumonia. J Clin Med. 2020;1(27):27-31."},{"title3":"Retrospective analysis of COVID-19 patients with different clinical subtypes"},{"title3":"CT findings in 2019 novel coronavirus disease (COVID-19) patients"},{"title3":"Application of chest CT examination in screening of patients with novel coronavirus pneumonia"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"CT manifestations and dynamic changes of coronavirus disease 2019"},{"title3":"Clinical diagnosis and treatment of critical patients with novel coronavirus pneumonia (report of 12 cases)"},{"title3":"Analysis of clinical and imaging features of novel coronavirus pneumonia in Chongqing traditional Chinese medicine system"},{"title3":"Clinical characteristics and CT signs of coronavirus disease 2019 (COVID-19) in the elderly"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Chest CT features of COVID-19"},{"title3":"Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia"},{"title3":"An update on the epidemiological characteristics of novel coronavirus pneumonia (COVID-19)"},{"title3":"Systematic solution of new coronavirus pneumonia in dead cadavers"},{"title3":"Study on the mechanism of liver enzyme abnormality in pneumonia infected by novel coronavirus"},{"title3":"Structure, function, and evolution of coronavirus spike proteins"},{"title3":"The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Molecular diagnosis of a novel coronavirus (2019-nCoV) causing an outbreak of pneumonia"},{"title3":"Correlation of chest CT and RT-PCR testing in coronavirus disease 2019 (COVID-19) in China: a report of 1014 cases"},{"title3":"Risk assessment of novel coronavirus COVID-19 outbreaks outside China"},{"title3":"Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study"},{"title3":"The neglected dimension of global security:a framework for countering infectious-disease crises"}]},{"title2":"Potential interventions for novel coronavirus in China: A systematic review","References":[{"title3":"Bats and coronaviruses"},{"title3":"Coronavirus envelope protein: current knowledge"},{"title3":"Middle East respiratory syndrome"},{"title3":"New SARS-like virus in China triggers alarm"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Coronaviruses: genome structure, replication, and pathogenesis"},{"title3":"Recent advances in the detection of respiratory virus infection in humans"},{"title3":"Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan"},{"title3":"Selenium, selenoproteins and viral infection"},{"title3":"Importance of vitamin A deficiency in pathology and immunology of viral infections"},{"title3":"Vitamin A and immunity to viral, bacterial and protozoan infections"},{"title3":"Vitamin A supplements ameliorate the adverse effect of HIV-1, malaria, and diarrheal infections on child growth"},{"title3":"Effects of dietary vitamin A content on antibody responses of feedlot calves inoculated intramuscularly with an inactivated bovine coronavirus vaccine"},{"title3":"Epithelia-damaging virus infections affect vitamin A status in chickens"},{"title3":"Retinoids inhibit measles virus through a type I IFN-dependent bystander effect"},{"title3":"Riboflavin (vitamin B-2) and health"},{"title3":"Inactivation of Middle East respiratory syndrome coronavirus (MERS-CoV) in plasma products using a riboflavin-based and ultraviolet light-based photochemical treatment"},{"title3":"C/EBPepsilon mediates nicotinamide-enhanced clearance of Staphylococcus aureus in mice"},{"title3":"Nicotinamide exacerbates hypoxemia in ventilator-induced lung injury independent of neutrophil infiltration"},{"title3":"Vitamin C and SARS coronavirus"},{"title3":"The effect of ascorbic acid on infection chick-embryo ciliated tracheal organ cultures by coronavirus"},{"title3":"Nutrients and their role in host resistance to infection"},{"title3":"Vitamin C intake and susceptibility to pneumonia"},{"title3":"Vitamin D insufficiency among free-living healthy young adults"},{"title3":"Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease"},{"title3":"Acute phase response elicited by experimental bovine diarrhea virus (BVDV) infection is associated with decreased vitamin D and E status of vitamin-replete preruminant calves"},{"title3":"Vitamin E metabolic effects and genetic variants: a challenge for precision nutrition in obesity and associated disturbances"},{"title3":"Vitamin E deficiency intensifies the myocardial injury of coxsackievirus B3 infection of mice"},{"title3":"Increased virulence of coxsackievirus B3 in mice due to vitamin E or selenium deficiency"},{"title3":"Macrophage-derived extracellular vesicles induce long-lasting immunity against hepatitis C virus which is blunted by polyunsaturated fatty acids"},{"title3":"Plasma fatty acid levels in patients with acquired immune deficiency syndrome and in controls"},{"title3":"The lipid mediator protectin D1 inhibits influenza virus replication and improves severe influenza"},{"title3":"Anti-HCV activities of selective polyunsaturated fatty acids"},{"title3":"Selenium and human health"},{"title3":"Micronutrients and host resistance to viral infection"},{"title3":"Review: micronutrient selenium deficiency influences evolution of some viral infectious diseases"},{"title3":"Selenium deficiency increases the pathology of an influenza virus infection"},{"title3":"Rapid genomic evolution of a non-virulent coxsackievirus B3 in selenium-deficient mice results in selection of identical virulent isolates"},{"title3":"Combined adjuvant effect of ginseng stem-leaf saponins and selenium on immune responses to a live bivalent vaccine of Newcastle disease virus and infectious bronchitis virus in chickens"},{"title3":"Zinc and immunity: an essential interrelation"},{"title3":"Zinc deficiency"},{"title3":"Zinc supplementation for the treatment of measles in children"},{"title3":"Zn(2+) inhibits coronavirus and arterivirus RNA polymerase activity in vitro and zinc ionophores block the replication of these viruses in cell culture"},{"title3":"Crossing the iron gate: why and how transferrin receptors mediate viral entry"},{"title3":"Childhood iron deficiency anemia leads to recurrent respiratory tract infections and gastroenteritis"},{"title3":"Chicken interferon type I inhibits infectious bronchitis virus replication and associated respiratory illness"},{"title3":"Prevention of experimental coronavirus colds with intranasal alpha-2b interferon"},{"title3":"Ribavirin and interferon-beta synergistically inhibit SARS-associated coronavirus replication in animal and human cell lines"},{"title3":"In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds"},{"title3":"Interferon priming enables cells to partially overturn the SARS coronavirus-induced block in innate immune activation"},{"title3":"Inhibition of SARS coronavirus infection in vitro with clinically approved antiviral drugs"},{"title3":"Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial"},{"title3":"Pegylated interferon-alpha protects type 1 pneumocytes against SARS coronavirus infection in macaques"},{"title3":"Proposal for vaccination against SARS coronavirus using avian infectious bronchitis virus strain H from The Netherlands"},{"title3":"Interferon alfacon-1 plus corticosteroids in severe acute respiratory syndrome: a preliminary study"},{"title3":"Current treatment options and the role of peptides as potential therapeutic components for Middle East Respiratory Syndrome (MERS): a review"},{"title3":"Uses of intravenous gammaglobulin in immune hematologic disease"},{"title3":"Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome"},{"title3":"Strokes, thromboembolic events, and IVIg: rare incidents blemish an excellent safety record"},{"title3":"Thymosin alpha 1 and HIV-1: recent advances and future perspectives"},{"title3":"A reappraisal of thymosin alpha1 in cancer therapy"},{"title3":"Serum thymosin alpha 1 levels in normal and pathological conditions"},{"title3":"Thymosin alpha 1 antagonizes dexamethasone and CD3-induced apoptosis of CD4+ CD8+ thymocytes through the activation of cAMP and protein kinase C dependent second messenger pathways"},{"title3":"Clinical investigation of outbreak of nosocomial severe acute respiratory syndrome"},{"title3":"Anti-SARS coronavirus agents: a patent review (2008-present)"},{"title3":"Modulation of immune response in aged humans through different administration modes of thymopentin"},{"title3":"Phase variation in the modulation of the human immune response"},{"title3":"Thymopentin as adjuvant in non-responders or hyporesponders to hepatitis B vaccination"},{"title3":"The general immunopharmacology of levamisole"},{"title3":"Lymphocyte subsets in measles. Depressed helper/inducer subpopulation reversed by in vitro treatment with levamisole and ascorbic acid"},{"title3":"Systemic cyclosporine and corneal transplantation"},{"title3":"Nucleocapsid protein of SARS coronavirus tightly binds to human cyclophilin A"},{"title3":"Factor in virus replication and potential target for anti-viral therapy"},{"title3":"The SARS-coronavirus-host interactome: identification of cyclophilins as target for pan-coronavirus inhibitors"},{"title3":"Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus"},{"title3":"Diarylheptanoids from Alnus japonica inhibit papain-like protease of severe acute respiratory syndrome coronavirus"},{"title3":"Cinanserin is an inhibitor of the 3C-like proteinase of severe acute respiratory syndrome coronavirus and strongly reduces virus replication in vitro"},{"title3":"Flavonoids: an overview"},{"title3":"Flavonoids from pterogyne nitens inhibit hepatitis C virus entry"},{"title3":"Inhibition of SARS-CoV 3CL protease by flavonoids"},{"title3":"Characteristics of flavonoids as potent MERS-CoV 3C-like protease inhibitors"},{"title3":"Biflavonoids from Torreya nucifera displaying SARS-CoV 3CL(pro) inhibition"},{"title3":"Angiotensin-converting enzyme-2: a molecular and cellular perspective"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"The secret life of ACE2 as a receptor for the SARS virus"},{"title3":"Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry"},{"title3":"Severe acute respiratory syndrome coronavirus entry into host cells: Opportunities for therapeutic intervention"},{"title3":"Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association"},{"title3":"Effects of chloroquine on viral infections: an old drug against today's diseases?"},{"title3":"Chloroquine is a potent inhibitor of SARS coronavirus infection and spread"},{"title3":"Membrane-related effects underlying the biological activity of the anthraquinones emodin and barbaloin"},{"title3":"Emodin blocks the SARS coronavirus spike protein and angiotensin-converting enzyme 2 interaction"},{"title3":"Old drugs as lead compounds for a new disease? Binding analysis of SARS coronavirus main proteinase with HIV, psychotic and parasite drugs"},{"title3":"The transition metal chelator nicotianamine is synthesized by filamentous fungi"},{"title3":"Nicotianamine is a novel angiotensin-converting enzyme 2 inhibitor in soybean"},{"title3":"Managing SARS amidst uncertainty"},{"title3":"Critics slam treatment for SARS as ineffective and perhaps dangerous"},{"title3":"Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area"},{"title3":"SARS: pharmacotherapy"},{"title3":"Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV"},{"title3":"Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings"},{"title3":"Combination therapy with lopinavir/ritonavir, ribavirin and interferon-alpha for Middle East respiratory syndrome"},{"title3":"Coronavirus susceptibility to the antiviral remdesivir (GS-5734) is mediated by the viral polymerase and the proofreading exoribonuclease"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Nelfinavir. A review of its therapeutic efficacy in HIV infection"},{"title3":"HIV protease inhibitor nelfinavir inhibits replication of SARS-associated coronavirus"},{"title3":"Arbidol as a broad-spectrum antiviral: an update"},{"title3":"Arbidol: a broad-spectrum antiviral compound that blocks viral fusion"},{"title3":"The synthetic antiviral drug arbidol inhibits globally prevalent pathogenic viruses"},{"title3":"[Antiviral activity of arbidol and its derivatives against the pathogen of severe acute respiratory syndrome in the cell cultures]"},{"title3":"Nitric oxide"},{"title3":"Nitric oxide and airway disease"},{"title3":"Efficacy of inhaled nitric oxide in patients with severe ARDS"},{"title3":"An overview on severe acute respiratory syndrome (SARS)"},{"title3":"Nitric oxide inhibits the replication cycle of severe acute respiratory syndrome coronavirus"},{"title3":"Efficacy of thioctic acid in the therapy of peripheral diabetic neuropathy"},{"title3":"Biochemical and clinical relevance of alpha lipoic acid: antioxidant and anti-inflammatory activity, molecular pathways and therapeutic potential"},{"title3":"Effects of dietary vitamin C, vitamin E, and alpha-lipoic acid supplementation on the antioxidant defense system and immune-related gene expression in broilers exposed to oxidative stress by dexamethasone"},{"title3":"Glucose-6-phosphate dehydrogenase deficiency enhances human coronavirus 229E infection"},{"title3":"Alpha-lipoic acid is an effective inhibitor of human immuno-deficiency virus (HIV-1) replication"},{"title3":"Sexual dimorphism in innate immune responses to infectious organisms"},{"title3":"Do men have a higher case fatality rate of severe acute respiratory syndrome than women do?"},{"title3":"SARS in Singapore--predictors of disease severity"},{"title3":"The pattern of Middle East respiratory syndrome coronavirus in Saudi Arabia: a descriptive epidemiological analysis of data from the Saudi Ministry of Health"},{"title3":"Sex-based differences in susceptibility to severe acute respiratory syndrome coronavirus infection"},{"title3":"Endocrine cells of the adenohypophysis in severe acute respiratory syndrome (SARS)"},{"title3":"Estrogenic compounds reduce influenza A virus replication in primary human nasal epithelial cells derived from female, but not male, donors"},{"title3":"Effective inhibition of MERS-CoV infection by resveratrol"},{"title3":"Virucidal activity of a scorpion venom peptide variant mucroporin-M1 against measles, SARS-CoV and influenza H5N1 viruses"},{"title3":"Severe acute respiratory syndrome vaccine development: experiences of vaccination against avian infectious bronchitis coronavirus"},{"title3":"Protection from SARS coronavirus conferred by live measles vaccine expressing the spike glycoprotein"},{"title3":"Live-attenuated bivalent measles virus-derived vaccines targeting Middle East respiratory syndrome coronavirus induce robust and multifunctional T cell responses against both viruses in an appropriate mouse model"},{"title3":"Measles-derived vaccines to prevent emerging viral diseases"},{"title3":"Human monoclonal antibody combination against SARS coronavirus: synergy and coverage of escape mutants"},{"title3":"Human monoclonal antibody as prophylaxis for SARS coronavirus infection in ferrets"},{"title3":"Convalescent plasma: new evidence for an old therapeutic tool?"},{"title3":"Feasibility, safety, clinical, and laboratory effects of convalescent plasma therapy for patients with Middle East respiratory syndrome coronavirus infection: a study protocol"},{"title3":"Use of convalescent plasma therapy in SARS patients in Hong Kong"},{"title3":"Retrospective comparison of convalescent plasma with continuing high-dose methylprednisolone treatment in SARS patients"}]},{"title2":"A Novel Coronavirus from patients with pneumonia in China, 2019","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Inferring the hosts of coronavirus using dual statistical models based on nucleotide composition"},{"title3":"Importation and human-to-human transmission of a novel coronavirus in Vietnam"},{"title3":"2019 novel coronavirus (2019-nCoV) outbreak: a new challenge"},{"title3":"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan"},{"title3":"Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China"},{"title3":"Novel Wuhan (2019-nCoV) coronavirus"},{"title3":"Severe acute respiratory syndrome coronavirus phylogeny: toward consensus"},{"title3":"Diagnosis and treatment of new coronavirus pneumonia (trial version 7) [J / OL]. Tianjin J Tradit Chin Med. 2020;1-5. http://kns.cnki.net/kcms/detail/12.1349.R.20200304.1638.006.html. Accessed 3 June 2020."},{"title3":"Clinical outcome of standardized oxygen therapy nursing strategy in COVID-19"},{"title3":"Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission"},{"title3":"Angiotensin-converting enzyme 2: a functional receptor for SARS coronavirus"},{"title3":"Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection"},{"title3":"High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa"},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis"},{"title3":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation"},{"title3":"Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways"},{"title3":"Significant changes of peripheral T lymphocyte subsets in patients with severe acute respiratory syndrome"},{"title3":"Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV"},{"title3":"Lactate dehydrogenase and C-reactive protein as predictors of respiratory failure in CoVID-19 patients"},{"title3":"Lactate dehydrogenase, an independent risk factor of severe COVID-19 patients: a retrospective and observational study"},{"title3":"C-reactive protein correlates with computed tomographic findings and predicts severe COVID-19 early"},{"title3":"Eosinopenia and elevated C-reactive protein facilitate triage of COVID-19 patients in fever clinic: a retrospective case-control study"},{"title3":"Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China"},{"title3":"Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19)"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Human ipsc-derived cardiomyocytes are susceptible to Sars-Cov-2 infection"},{"title3":"Cardiovascular complications in COVID-19"},{"title3":"COVID-19 pandemic and troponin: indirect myocardial injury, myocardial inflammation or myocarditis?"},{"title3":"Endothelial cell infection and endotheliitis in COVID-19"}]}]}]}